{"T8": {"n": 8, "t": "Dermatology, Community Medicine & Forensic", "d": "Oct 6 2026", "q": [{"n": 1, "s": "A 25-year-old woman has stable, localised vitiligo patches on her face. She wants treatment. What is the most appropriate first-line option for the face?", "o": [["A", "Oral PUVA as first line"], ["B", "Systemic corticosteroid pulses"], ["C", "Skin grafting"], ["D", "Topical tacrolimus"]], "c": ["D)", "Topical tacrolimus"], "co": "Vitiligo management — topical tacrolimus for facial lesions", "ct": "Interpretation", "w": "Localised vitiligo is treated with potent topical steroids or topical tacrolimus on the face (steroid-sparing, avoids steroid atrophy); phototherapy (NB-UVB preferred) is the mainstay for more extensive disease.", "d": "The stem pins two facts: localised + facial — which selects topical tacrolimus.", "t": "Location and stability drive vitiligo management — face shifts to tacrolimus.", "f": "Vitiligo: localised → potent steroids/tacrolimus (face); extensive → NB-UVB; grafting for stable small areas.", "r": "Localised vitiligo is treated with potent topical steroids or topical tacrolimus on the face (steroid-sparing, avoids steroid atrophy); phototherapy (NB-UVB preferred) is the mainstay for more extensive disease.", "x": [["A) Oral PUVA as first line", "Oral PUVA is not first-line; NB-UVB phototherapy is preferred and reserved for extensive disease."], ["B) Systemic corticosteroid pulses", "Rapidly progressive disease uses oral steroid pulses, not stable localised lesions."], ["C) Skin grafting", "Skin grafting is for stable, small lesions, not the immediate first-line choice."]]}, {"n": 2, "s": "An 18-year-old woman is about to start isotretinoin for severe nodulocystic acne. Which measure is mandatory before and during treatment?", "o": [["A", "Monthly eye examination"], ["B", "Weekly full blood count"], ["C", "Two forms of contraception and monthly pregnancy testing"], ["D", "Annual electrocardiogram"]], "c": ["C)", "Two forms of contraception and monthly pregnancy testing"], "co": "Isotretinoin — teratogenicity requires dual contraception plus pregnancy tests", "ct": "Recall", "w": "Isotretinoin is profoundly teratogenic; females need two forms of contraception plus monthly pregnancy tests, along with monthly LFTs and lipid monitoring.", "d": "Isotretinoin + woman of reproductive age — the exam answer is always dual contraception.", "t": "Drug-safety priority — teratogenicity beats every other monitoring detail for isotretinoin.", "f": "Isotretinoin: dual contraception + monthly pregnancy test, LFTs, lipids; cumulative 120-150 mg/kg.", "r": "Isotretinoin is profoundly teratogenic; females need two forms of contraception plus monthly pregnancy tests, along with monthly LFTs and lipid monitoring.", "x": [["A) Monthly eye examination", "Ophthalmology review is not the mandatory monthly monitor; teratogenicity is the core concern."], ["B) Weekly full blood count", "LFTs and lipids are the blood monitors — monitored monthly, not weekly FBC."], ["D) Annual electrocardiogram", "ECG is not part of isotretinoin monitoring."]]}, {"n": 3, "s": "After applying permethrin 5% cream overnight for scabies, the application is repeated after one week. What is the reason for this second application?", "o": [["A", "To kill mites hatching from eggs present at the first application"], ["B", "It is unnecessary — a single application always suffices"], ["C", "To treat bacterial superinfection"], ["D", "To prevent post-scabetic itch"]], "c": ["A)", "To kill mites hatching from eggs present at the first application"], "co": "Scabies — repeat application after 1 week to hit newly hatched mites", "ct": "Recall", "w": "Permethrin is repeated after one week because eggs survive the first application; the second dose kills mites hatching in the interim and prevents reinfestation.", "d": "The rationale for the scheduled repeat is the egg-hatch cycle — the stem asks exactly that.", "t": "Mechanism of schedule — the 1-week repeat targets the egg-hatch cycle, not symptom persistence.", "f": "Scabies: permethrin overnight, repeat after 1 week (egg hatch); treat all family members; itch may persist 2-4 weeks.", "r": "Permethrin is repeated after one week because eggs survive the first application; the second dose kills mites hatching in the interim and prevents reinfestation.", "x": [["B) It is unnecessary — a single application always suffices", "Guidelines mandate the repeat; single application leaves hatching eggs untreated."], ["C) To treat bacterial superinfection", "Superinfection is treated separately with antibiotics, not extra scabicide."], ["D) To prevent post-scabetic itch", "Post-scabetic itch persists 2-4 weeks and is hypersensitivity, not a reason to retreat."]]}, {"n": 4, "s": "A 28-year-old woman has sharply demarcated depigmented macules over the hands and around the mouth, with a white forelock. Which autoimmune condition is most commonly associated with this disorder?", "o": [["A", "Addison disease"], ["B", "Pernicious anaemia"], ["C", "Thyroid disease"], ["D", "Type 1 diabetes mellitus"]], "c": ["C)", "Thyroid disease"], "co": "Vitiligo — most common autoimmune association is thyroid disease", "ct": "Recall", "w": "Vitiligo is an autoimmune destruction of melanocytes; thyroid disease (hypo/hyperthyroidism) is the most commonly associated autoimmune condition, so screening is advised.", "d": "\"Sharply demarcated depigmented macules + white forelock\" is vitiligo; the question asks its classic association.", "t": "Most-common ladder — thyroid disease is the number one vitiligo association in exams.", "f": "Vitiligo → screen thyroid; associations ladder: thyroid > others.", "r": "Vitiligo is an autoimmune destruction of melanocytes; thyroid disease (hypo/hyperthyroidism) is the most commonly associated autoimmune condition, so screening is advised.", "x": [["A) Addison disease", "Addison disease is associated but far less common than thyroid disease in vitiligo."], ["B) Pernicious anaemia", "Pernicious anaemia is associated with vitiligo but is not the most frequent."], ["D) Type 1 diabetes mellitus", "Type 1 diabetes co-occurs, but thyroid disease tops the list."]]}, {"n": 5, "s": "A dermatologist plans isotretinoin for a young man with severe nodulocystic acne. What cumulative dose is the usual treatment target?", "o": [["A", "50-75 mg/kg"], ["B", "80-100 mg/kg"], ["C", "200-250 mg/kg"], ["D", "120-150 mg/kg"]], "c": ["D)", "120-150 mg/kg"], "co": "Power number — isotretinoin cumulative dose 120-150 mg/kg", "ct": "Recall", "w": "The standard cumulative isotretinoin target is 120-150 mg/kg (at 0.5-1 mg/kg/day), which lowers relapse rates in severe acne.", "d": "The stem asks the cumulative target — 120-150 mg/kg is the fixed power number.", "t": "Number lock — cumulative 120-150 mg/kg; daily dose is 0.5-1 mg/kg/day — do not mix.", "f": "Isotretinoin: 0.5-1 mg/kg/day, cumulative 120-150 mg/kg; monitor LFTs, lipids, pregnancy.", "r": "The standard cumulative isotretinoin target is 120-150 mg/kg (at 0.", "x": [["A) 50-75 mg/kg", "50-75 mg/kg is far below the relapse-reducing cumulative target."], ["B) 80-100 mg/kg", "80-100 mg/kg is insufficient as a course target."], ["C) 200-250 mg/kg", "200-250 mg/kg exceeds the standard course and adds toxicity without benefit."]]}, {"n": 6, "s": "A farmer in a rural area has a painless chronic ulcer with a raised violaceous border on his forearm, following an insect bite months earlier. Which vector transmits the causative organism?", "o": [["A", "Anopheles mosquito"], ["B", "Culex mosquito"], ["C", "Tsetse fly"], ["D", "Phlebotomus sandfly"]], "c": ["D)", "Phlebotomus sandfly"], "co": "Cutaneous leishmaniasis — Phlebotomus sandfly vector", "ct": "Interpretation", "w": "A painless chronic ulcer with a violaceous border after a bite is cutaneous leishmaniasis, transmitted by the Phlebotomus sandfly (Leishmania tropica/L. major).", "d": "Painless chronic ulcer + violaceous border + bite history is the leishmaniasis vignette; the vector question follows.", "t": "Vector map — Phlebotomus sandfly is the leishmaniasis vector; it is the only one on the list.", "f": "Leishmaniasis: painless ulcer + violaceous border + sandfly bite; vector = Phlebotomus.", "r": "A painless chronic ulcer with a violaceous border after a bite is cutaneous leishmaniasis, transmitted by the Phlebotomus sandfly (Leishmania tropica/L.", "x": [["A) Anopheles mosquito", "Anopheles mosquitoes transmit malaria."], ["B) Culex mosquito", "Culex mosquitoes transmit filariasis and West Nile virus."], ["C) Tsetse fly", "Tsetse flies transmit African trypanosomiasis."]]}, {"n": 7, "s": "A 50-year-old man with dark skin has a rapidly enlarging pigmented lesion on the sole of his foot with irregular borders. Which melanoma subtype is most likely?", "o": [["A", "Superficial spreading melanoma"], ["B", "Nodular melanoma"], ["C", "Acral lentiginous melanoma"], ["D", "Lentigo maligna melanoma"]], "c": ["C)", "Acral lentiginous melanoma"], "co": "Acral lentiginous melanoma — palms, soles, nail beds; common in dark skin", "ct": "Interpretation", "w": "Acral lentiginous melanoma arises on palms, soles and subungual sites and is the most common melanoma subtype in Asian and Black populations.", "d": "\"Sole of the foot in a dark-skinned patient\" is the acral lentiginous location clue.", "t": "Population-site map — acral lentiginous owns palms/soles/nail beds, especially in darker skin.", "f": "Acral lentiginous melanoma: palms, soles, subungual — commonest subtype in Asian/Black patients.", "r": "Acral lentiginous melanoma arises on palms, soles and subungual sites and is the most common melanoma subtype in Asian and Black populations.", "x": [["A) Superficial spreading melanoma", "Superficial spreading melanoma is the commonest subtype in fair-skinned populations on intermittently sun-exposed skin."], ["B) Nodular melanoma", "Nodular melanoma is a rapidly growing nodule but is not site-selective for the sole."], ["D) Lentigo maligna melanoma", "Lentigo maligna melanoma occurs on chronically sun-damaged facial skin of the elderly."]]}, {"n": 8, "s": "A 28-year-old woman has multiple tender erythematous nodules over the anterior shins with low-grade fever. In Pakistan, which underlying causes should be actively sought?", "o": [["A", "Systemic lupus erythematosus"], ["B", "Rheumatoid arthritis"], ["C", "Drug allergy"], ["D", "Tuberculosis, sarcoidosis and streptococcal infection"]], "c": ["D)", "Tuberculosis, sarcoidosis and streptococcal infection"], "co": "Erythema nodosum — TB, sarcoidosis, streptococcal causes", "ct": "Interpretation", "w": "Erythema nodosum (tender anterior shin nodules = septal panniculitis) is a reactive pattern; in our setting TB, sarcoidosis and streptococcal infection head the workup list.", "d": "Tender shin nodules = erythema nodosum; the question localises the cause list to Pakistan, where TB leads.", "t": "Setting-shifted workup — the geographically relevant list (TB/sarcoid/strep) beats generic causes.", "f": "Erythema nodosum: tender anterior shin nodules; Pakistan workup → TB, sarcoidosis, strep.", "r": "Erythema nodosum (tender anterior shin nodules = septal panniculitis) is a reactive pattern; in our setting TB, sarcoidosis and streptococcal infection head the workup list.", "x": [["A) Systemic lupus erythematosus", "SLE is not a primary cause of erythema nodosum."], ["B) Rheumatoid arthritis", "Rheumatoid arthritis is not an erythema nodosum cause."], ["C) Drug allergy", "Drugs are a recognised cause but fungal \"drug allergy\" is not the lead answer in this setting."]]}, {"n": 9, "s": "A 45-year-old man with chronic plaque psoriasis has skin biopsy showing a thickened stratum corneum with retained nuclei in the keratinocytes. Which histopathology term describes the retained-nuclei finding?", "o": [["A", "Hyperkeratosis"], ["B", "Parakeratosis"], ["C", "Acanthosis"], ["D", "Spongiosis"]], "c": ["B)", "Parakeratosis"], "co": "Histopathology terminology — parakeratosis", "ct": "Recall", "w": "Parakeratosis is retained nuclei in the stratum corneum, classically seen in psoriasis. Hyperkeratosis (thickened corneum) coexists in psoriasis but is not the retained-nuclei finding.", "d": "The stem asks specifically for the retained-nuclei feature, not the simple thickening.", "t": "Term-swap — hyperkeratosis and parakeratosis coexist in psoriasis; the question targets the retained nuclei.", "f": "Parakeratosis = retained nuclei in corneum → psoriasis; hyperkeratosis = thickened corneum without nuclei.", "r": "Parakeratosis is retained nuclei in the stratum corneum, classically seen in psoriasis.", "x": [["A) Hyperkeratosis", "Hyperkeratosis is thickening of the stratum corneum — but no retained nuclei."], ["C) Acanthosis", "Acanthosis is thickening of the stratum spinosum (e.g. acanthosis nigricans)."], ["D) Spongiosis", "Spongiosis is intercellular oedema of the epidermis — the hallmark of eczema."]]}, {"n": 10, "s": "A patient with acanthosis nigricans has biopsy showing thickened stratum spinosum. Which histopathology term describes this thickening?", "o": [["A", "Parakeratosis"], ["B", "Hyperkeratosis"], ["C", "Acantholysis"], ["D", "Acanthosis"]], "c": ["D)", "Acanthosis"], "co": "Histopathology terminology — acanthosis", "ct": "Recall", "w": "Acanthosis is thickening of the stratum spinosum — and it names the disease acanthosis nigricans.", "d": "\"Thickened stratum spinosum\" is the literal definition of acanthosis.", "t": "Lookalike pair — acanthosis (thickening) vs acantholysis (breaking apart); one letter apart.", "f": "Acanthosis = thickened spinosum; acantholysis = lost adhesion; do not swap.", "r": "Acanthosis is thickening of the stratum spinosum — and it names the disease acanthosis nigricans.", "x": [["A) Parakeratosis", "Parakeratosis is retained nuclei in the stratum corneum (psoriasis)."], ["B) Hyperkeratosis", "Hyperkeratosis thickens the stratum corneum, not the spinosum."], ["C) Acantholysis", "Acantholysis is loss of cell-cell adhesion (pemphigus)."]]}, {"n": 11, "s": "A 2-year-old with atopic dermatitis develops fever and widespread painful vesicles with punched-out erosions over the eczematous skin within 24 hours. What is the most appropriate next step?", "o": [["A", "Topical mupirocin to erosions"], ["B", "Oral antihistamines and observe"], ["C", "Increase topical steroid potency"], ["D", "IV acyclovir"]], "c": ["D)", "IV acyclovir"], "co": "Eczema herpeticum — disseminated HSV on eczema is an emergency", "ct": "Interpretation", "w": "Eczema herpeticum is disseminated HSV superinfection of eczematous skin and is a medical emergency requiring IV acyclovir.", "d": "\"Punctuated vesicles + punched-out erosions + fever\" in an atopic child is the eczema herpeticum pattern.", "t": "Emergency override — eczema herpeticum outranks routine eczema care; answer IV acyclovir, not antibiotics.", "f": "Eczema herpeticum = IV acyclovir; impetiginized eczema = mupirocin/oral antibiotics — know which is which.", "r": "Eczema herpeticum is disseminated HSV superinfection of eczematous skin and is a medical emergency requiring IV acyclovir.", "x": [["A) Topical mupirocin to erosions", "Mupirocin treats bacterial impetiginization, not disseminated HSV."], ["B) Oral antihistamines and observe", "Observation with antihistamines would delay emergency antiviral therapy."], ["C) Increase topical steroid potency", "More topical steroid is contraindicated — infection is the issue."]]}, {"n": 12, "s": "A 70-year-old man has a basal cell carcinoma being treated surgically. For which location is Mohs micrographic surgery most likely to be added?", "o": [["A", "Face"], ["B", "Back"], ["C", "Lower legs"], ["D", "Abdomen"]], "c": ["A)", "Face"], "co": "Mohs surgery — cosmetically sensitive facial locations", "ct": "Recall", "w": "Mohs micrographic surgery is preferred for BCC in cosmetically sensitive areas such as the face, where tissue-sparing margin control matters; excisional surgery elsewhere cures >95%.", "d": "The stem asks where Mohs is added — the face is the specified cosmetically sensitive zone.", "t": "Site-specific surgery — Mohs = face/cosmetically sensitive; trunk/extremities = simple excision.", "f": "BCC: surgical excision with clear margins (cure >95%); Mohs for face; cryotherapy/radiation for poor candidates.", "r": "Mohs micrographic surgery is preferred for BCC in cosmetically sensitive areas such as the face, where tissue-sparing margin control matters; excisional surgery elsewhere cures >95%.", "x": [["B) Back", "Back lesions are low-risk sites where simple excision with clear margins suffices."], ["C) Lower legs", "Lower legs are non-cosmetic sites; simple excision is standard."], ["D) Abdomen", "Abdomen is not a Mohs-priority site."]]}, {"n": 13, "s": "A 65-year-old man presents with a painful shingles rash on the trunk. Antiviral therapy is most effective if started within which window?", "o": [["A", "Within 1 week of crusting"], ["B", "Within 72 hours of rash onset"], ["C", "Only after postherpetic neuralgia develops"], ["D", "Only in immunocompromised patients"]], "c": ["B)", "Within 72 hours of rash onset"], "co": "Power number — zoster antivirals within 72 hours", "ct": "Recall", "w": "Antivirals (acyclovir/valacyclovir) for herpes zoster must be started within 72 hours of rash onset to reduce acute pain and the risk of postherpetic neuralgia.", "d": "The stem asks the therapy window — 72 hours from rash onset is the fixed number.", "t": "Number lock — 72 hours is the zoster antiviral window; do not stretch it.", "f": "Zoster antivirals within 72 hours of rash onset; PHN = pain >3 months after healing.", "r": "Antivirals (acyclovir/valacyclovir) for herpes zoster must be started within 72 hours of rash onset to reduce acute pain and the risk of postherpetic neuralgia.", "x": [["A) Within 1 week of crusting", "Crusting means the replicative phase has passed; starting then is too late for maximal benefit."], ["C) Only after postherpetic neuralgia develops", "Waiting for PHN is wrong — antivirals are preventive, given early."], ["D) Only in immunocompromised patients", "Antivirals benefit immunocompetent patients within the window as well."]]}, {"n": 14, "s": "A 30-year-old man with coeliac disease develops intensely pruritic grouped vesicles on the elbows and knees. DIF shows granular IgA at the dermal papillae tips. Before starting dapsone, which blood test is essential?", "o": [["A", "G6PD level"], ["B", "Serum creatinine"], ["C", "Thyroid function tests"], ["D", "Chest X-ray"]], "c": ["A)", "G6PD level"], "co": "Dermatitis herpetiformis — dapsone and G6PD screening", "ct": "Interpretation", "w": "DH (pruritic grouped vesicles on extensors, granular IgA at dermal papillae, coeliac link) responds dramatically to dapsone, but dapsone causes haemolysis — check G6PD first.", "d": "The stem plants the DH diagnosis and the dapsone start; G6PD is the pre-dapsone safety check.", "t": "Drug-safety hook — every dapsone question in exams is about G6PD screening.", "f": "Dapsone: dramatic 48-h response in DH, but check G6PD first (haemolysis risk).", "r": "DH (pruritic grouped vesicles on extensors, granular IgA at dermal papillae, coeliac link) responds dramatically to dapsone, but dapsone causes haemolysis — check G6PD first.", "x": [["B) Serum creatinine", "Renal monitoring matters for other drugs; dapsone has haemolysis as its key risk in G6PD deficiency."], ["C) Thyroid function tests", "Thyroid tests are not a dapsone prerequisite."], ["D) Chest X-ray", "Chest X-ray screens sarcoidosis/TB, not dapsone toxicity."]]}, {"n": 15, "s": "A 35-year-old woman has itchy purple, flat-topped, polygonal papules on the flexor wrists with fine white lace-like lines on the surface. Before starting treatment, which serology is important?", "o": [["A", "Hepatitis C serology and LFTs"], ["B", "Hepatitis B surface antigen"], ["C", "HIV antibody test"], ["D", "EBV serology"]], "c": ["A)", "Hepatitis C serology and LFTs"], "co": "Lichen planus association with hepatitis C", "ct": "Interpretation", "w": "Lichen planus (pruritic, purple, polygonal, planar papules with Wickham striae) is associated with hepatitis C; LFTs and HCV serology are checked.", "d": "\"Purple polygonal planar papules + Wickham striae on flexor wrists\" is lichen planus, and the stem asks for its key association.", "t": "Hepatitis letter swap — HCV (C) is the lichen planus association, not HBV.", "f": "Lichen planus → check HCV serology + LFTs; remember the 6 Ps.", "r": "Lichen planus (pruritic, purple, polygonal, planar papules with Wickham striae) is associated with hepatitis C; LFTs and HCV serology are checked.", "x": [["B) Hepatitis B surface antigen", "HBV is not the recognised lichen planus association — HCV is."], ["C) HIV antibody test", "HIV does not drive lichen planus workup; molluscum/leishmaniasis vigilance does."], ["D) EBV serology", "EBV is not linked with lichen planus."]]}, {"n": 16, "s": "In bullous pemphigoid, the autoantibodies are directed against which structure of the basement membrane zone?", "o": [["A", "Desmoglein 3"], ["B", "Type VII collagen"], ["C", "Tissue transglutaminase"], ["D", "Hemidesmosomal proteins BP180/BP230"]], "c": ["D)", "Hemidesmosomal proteins BP180/BP230"], "co": "Bullous pemphigoid — anti-BP180/BP230 hemidesmosomal antibodies", "ct": "Recall", "w": "Bullous pemphigoid targets hemidesmosomal proteins BP180 (BPAG2) and BP230 (BPAG1) at the basement membrane zone, giving linear IgG on DIF.", "d": "The stem names the disease; the question is the molecular target — hemidesmosomes.", "t": "Antibody-mapping — BP targets hemidesmosomes; the pemphigus group targets desmogleins.", "f": "BP180/BP230 → hemidesmosomes; desmogleins → pemphigus; type VII collagen → EBA.", "r": "Bullous pemphigoid targets hemidesmosomal proteins BP180 (BPAG2) and BP230 (BPAG1) at the basement membrane zone, giving linear IgG on DIF.", "x": [["A) Desmoglein 3", "Desmoglein 3 is the pemphigus vulgaris target, giving suprabasal acantholysis."], ["B) Type VII collagen", "Type VII collagen is attacked in epidermolysis bullosa acquisita, not BP."], ["C) Tissue transglutaminase", "Tissue transglutaminase relates to coeliac disease, a dermatitis herpetiformis association."]]}, {"n": 17, "s": "A 30-year-old woman develops an itchy erythematous rash with sharp geometric borders exactly where henna was applied to her hands, appearing 36 hours after application. What is the underlying mechanism?", "o": [["A", "Type I IgE-mediated immediate hypersensitivity"], ["B", "Delayed Type IV hypersensitivity"], ["C", "Type II antibody-mediated cytotoxicity"], ["D", "Type III immune-complex deposition"]], "c": ["B)", "Delayed Type IV hypersensitivity"], "co": "Contact dermatitis mechanism — Type IV delayed hypersensitivity", "ct": "Interpretation", "w": "Allergic contact dermatitis is a Type IV delayed hypersensitivity developing 24-72 hours after allergen contact (here henna/PPD) — never immediate.", "d": "The 36-hour delay and the sharp geometric borders exactly matching the contact site are the decisive clues.", "t": "Timing trap — delayed (24-72 h) not immediate; classic MCQ discriminator for contact dermatitis.", "f": "Contact dermatitis = 24-72 h delay; never answer \"immediate hypersensitivity\".", "r": "Allergic contact dermatitis is a Type IV delayed hypersensitivity developing 24-72 hours after allergen contact (here henna/PPD) — never immediate.", "x": [["A) Type I IgE-mediated immediate hypersensitivity", "Type I IgE reactions are immediate (minutes), e.g. urticaria/anaphylaxis, not 36 hours later."], ["C) Type II antibody-mediated cytotoxicity", "Type II reactions target cell-surface antigens with complement, not allergen contact sites."], ["D) Type III immune-complex deposition", "Type III immune-complex disease (e.g. serum sickness) does not produce contact-bordered eruptions."]]}, {"n": 18, "s": "A patient with pemphigus vulgaris has biopsy findings of keratinocytes losing cell-to-cell adhesion in the stratum spinosum. Which term describes this loss of adhesion?", "o": [["A", "Spongiosis"], ["B", "Parakeratosis"], ["C", "Acantholysis"], ["D", "Hyperkeratosis"]], "c": ["C)", "Acantholysis"], "co": "Histopathology terminology — acantholysis", "ct": "Recall", "w": "Acantholysis is the loss of cell-cell adhesion (desmosome disruption), the defining lesion of pemphigus vulgaris.", "d": "\"Loss of cell-cell adhesion\" is the direct definition of acantholysis.", "t": "Definition-flip — know acantholysis (adhesion loss) vs spongiosis (oedema); both involve the spinosum.", "f": "Acantholysis → pemphigus group; spongiosis → eczema; memorise the pair.", "r": "Acantholysis is the loss of cell-cell adhesion (desmosome disruption), the defining lesion of pemphigus vulgaris.", "x": [["A) Spongiosis", "Spongiosis is intercellular oedema, typical of eczema — not loss of adhesion."], ["B) Parakeratosis", "Parakeratosis is retained nuclei in the stratum corneum (psoriasis)."], ["D) Hyperkeratosis", "Hyperkeratosis is thickened stratum corneum, unrelated to adhesion loss."]]}, {"n": 19, "s": "A 30-year-old man has recurrent crops of target lesions on the palms and soles, each episode following a cold sore. What is the most appropriate management?", "o": [["A", "Early or suppressive antiviral therapy with acyclovir"], ["B", "Systemic corticosteroids as first-line"], ["C", "Dapsone"], ["D", "Topical antifungal therapy"]], "c": ["A)", "Early or suppressive antiviral therapy with acyclovir"], "co": "Erythema multiforme — HSV-triggered, treat the trigger with antivirals", "ct": "Interpretation", "w": "Recurrent erythema multiforme is most often triggered by herpes simplex; early (or suppressive) acyclovir reduces recurrences, whereas steroids are not first-line.", "d": "\"Target lesions + cold sore trigger\" is the HSV-driven recurrent EM pattern — treat HSV.", "t": "Trigger therapy — recurrent EM answers with antivirals against the HSV driver.", "f": "Erythema multiforme: target lesions, palms/soles, HSV-triggered → early/suppressive acyclovir.", "r": "Recurrent erythema multiforme is most often triggered by herpes simplex; early (or suppressive) acyclovir reduces recurrences, whereas steroids are not first-line.", "x": [["B) Systemic corticosteroids as first-line", "Systemic steroids are not first-line for HSV-triggered EM and may worsen the viral trigger."], ["C) Dapsone", "Dapsone is for dermatititis herpetiformis, not EM."], ["D) Topical antifungal therapy", "Antifungals target tinea, not EM."]]}, {"n": 20, "s": "A 6-month-old infant has weeping crusted lesions on the face and extensor surfaces; the diaper area is spared. The mother reports intense itching and a family history of asthma. Which diagnosis fits best?", "o": [["A", "Atopic dermatitis"], ["B", "Seborrheic dermatitis"], ["C", "Contact dermatitis"], ["D", "Scabies"]], "c": ["A)", "Atopic dermatitis"], "co": "Age-based distribution of atopic dermatitis", "ct": "Interpretation", "w": "Infantile atopic dermatitis classically affects face, scalp and extensor surfaces with sparing of the diaper area, with the atopic family history supporting it.", "d": "Infant age + extensor/face distribution + diaper-area sparing is the infantile atopic dermatitis pattern.", "t": "Age-distribution map — infants: face/extensors (diaper spared); children: flexures; adults: hands/wrists.", "f": "Atopic dermatitis distribution flips extensor→flexural as the child grows.", "r": "Infantile atopic dermatitis classically affects face, scalp and extensor surfaces with sparing of the diaper area, with the atopic family history supporting it.", "x": [["B) Seborrheic dermatitis", "Seborrheic dermatitis presents with greasy yellow scales on sebaceous areas (cradle cap), not weeping extensor lesions."], ["C) Contact dermatitis", "Contact dermatitis follows a geometric allergen-contact distribution, not this age pattern."], ["D) Scabies", "Scabies causes nocturnal pruritus with burrows in web spaces and affects family members."]]}, {"n": 21, "s": "An infant develops widespread flaccid bullae on the trunk and face that rupture easily, leaving shallow erosions. Which organism is most likely responsible?", "o": [["A", "Streptococcus pyogenes"], ["B", "Streptococcus pneumoniae"], ["C", "Pseudomonas aeruginosa"], ["D", "Staphylococcus aureus producing exfoliative toxin"]], "c": ["D)", "Staphylococcus aureus producing exfoliative toxin"], "co": "Bullous impetigo — S. aureus exotoxin", "ct": "Interpretation", "w": "Bullous impetigo is caused by Staphylococcus aureus exotoxin producing flaccid bullae that rupture easily, typically on trunk and face.", "d": "\"Flaccid bullae that rupture easily\" is the bullous impetigo signature, contrasting with the honey-coloured crust of non-bullous impetigo.", "t": "Bullous vs non-bullous — both are impetigo but the toxin-driven bullous form is staphylococcal.", "f": "Bullous impetigo = S. aureus exotoxin; non-bullous = S. aureus + S. pyogenes.", "r": "Bullous impetigo is caused by Staphylococcus aureus exotoxin producing flaccid bullae that rupture easily, typically on trunk and face.", "x": [["A) Streptococcus pyogenes", "S. pyogenes (GAS) causes non-bullous impetigo with honey-coloured crusts, not flaccid bullae."], ["B) Streptococcus pneumoniae", "S. pneumoniae is not an impetigo pathogen."], ["C) Pseudomonas aeruginosa", "Pseudomonas is a hot-tub folliculitis/otitis pathogen, not bullous impetigo."]]}, {"n": 22, "s": "A 6-week-old infant has intensely pruritic burrows between the fingers and in the axillae; several family members itch at night. Which first-line scabicide is safest here?", "o": [["A", "Permethrin 5% cream"], ["B", "Oral ivermectin"], ["C", "Sulfur 5-10% ointment"], ["D", "Lindane lotion"]], "c": ["C)", "Sulfur 5-10% ointment"], "co": "Scabies in infants <2 months — sulfur ointment", "ct": "Recall", "w": "In pregnancy and infants under 2 months, permethrin and ivermectin are avoided; sulfur 5-10% ointment is the scabicide of choice.", "d": "The stem pins the age (<2 months), which flips the first-line choice to sulfur.", "t": "Age-exception — the textbook first-line (permethrin) is wrong below 2 months; sulfur wins.", "f": "Scabies: permethrin first-line; sulfur 5-10% in pregnancy/infants <2 months; treat all family members.", "r": "In pregnancy and infants under 2 months, permethrin and ivermectin are avoided; sulfur 5-10% ointment is the scabicide of choice.", "x": [["A) Permethrin 5% cream", "Permethrin 5% is the general first-line but is avoided in this age group (<2 months)."], ["B) Oral ivermectin", "Oral ivermectin is an alternative for older patients, not a 6-week-old infant."], ["D) Lindane lotion", "Lindane is neurotoxic and should not be used in infants."]]}, {"n": 23, "s": "A patient had shingles with the rash now healed, but the pain persists for 4 months. What is this condition called?", "o": [["A", "Acute zoster pain"], ["B", "Recurrent herpes zoster"], ["C", "Postherpetic neuralgia"], ["D", "Chronic pruritus syndrome"]], "c": ["C)", "Postherpetic neuralgia"], "co": "Power number — PHN is pain persisting beyond 3 months", "ct": "Recall", "w": "Postherpetic neuralgia is defined as pain persisting more than 3 months after the zoster rash has healed.", "d": "Persistent pain at 4 months crosses the 3-month post-healing threshold — PHN.", "t": "Threshold number — >3 months of pain after healing is the PHN definition.", "f": "PHN = pain >3 months after zoster healing; risk factors: age, severe acute pain.", "r": "Postherpetic neuralgia is defined as pain persisting more than 3 months after the zoster rash has healed.", "x": [["A) Acute zoster pain", "Acute zoster pain accompanies the active rash phase, not months after healing."], ["B) Recurrent herpes zoster", "Recurrent zoster would show a new rash, not pain alone."], ["D) Chronic pruritus syndrome", "Pruritus is itch, not pain."]]}, {"n": 24, "s": "A 17-year-old boy suddenly develops painful ulcerating nodules over the chest and back with fever and arthralgia, while the acne flares dramatically. What is the appropriate treatment approach?", "o": [["A", "Begin isotretinoin at full dose"], ["B", "Oral doxycycline alone"], ["C", "Topical retinoids only"], ["D", "Systemic corticosteroids"]], "c": ["D)", "Systemic corticosteroids"], "co": "Acne fulminans — systemic corticosteroids required", "ct": "Interpretation", "w": "Acne fulminans (ulcerating acne with fever and arthralgia) is a systemic inflammatory eruption that requires systemic corticosteroids, typically with cautious isotretinoin later.", "d": "Sudden ulcerating acne + fever + arthralgia is the acne fulminans triad — corticosteroids, not routine acne drugs.", "t": "Distinct entity — fever + arthralgia moves the answer from acne routine to systemic steroids.", "f": "Acne fulminans: ulcerating acne + fever + arthralgia → systemic corticosteroids.", "r": "Acne fulminans (ulcerating acne with fever and arthralgia) is a systemic inflammatory eruption that requires systemic corticosteroids, typically with cautious isotretinoin later.", "x": [["A) Begin isotretinoin at full dose", "Full-dose isotretinoin can flare acne fulminans further; it is introduced cautiously after steroids."], ["B) Oral doxycycline alone", "Doxycycline treats ordinary inflammatory acne but not the systemic flares of fulminans."], ["C) Topical retinoids only", "Topical therapy is far too weak for a febrile illness."]]}, {"n": 25, "s": "An elderly man has an enlarging ulcer inside a chronic burn scar on his leg. Biopsy shows atypical keratinocytes invading the dermis. Which entity does this represent?", "o": [["A", "Viral-induced benign ulcer"], ["B", "Squamous cell carcinoma arising in a chronic scar"], ["C", "Basal cell carcinoma variant with pearly borders"], ["D", "Stage IV pressure ulcer"]], "c": ["B)", "Squamous cell carcinoma arising in a chronic scar"], "co": "Marjolin ulcer — SCC in a chronic wound or burn scar", "ct": "Interpretation", "w": "A Marjolin ulcer is a squamous cell carcinoma arising in a chronic wound or burn scar — it is aggressive with high metastatic potential.", "d": "\"Ulcer inside a chronic burn scar + invasive keratinocytes\" defines Marjolin ulcer.", "t": "Name lock — chronic scar + SCC = Marjolin ulcer; expect the \"aggressive, metastatic\" follow-up.", "f": "Marjolin ulcer = SCC in chronic scar/burn wound — aggressive, high metastasis risk.", "r": "A Marjolin ulcer is a squamous cell carcinoma arising in a chronic wound or burn scar — it is aggressive with high metastatic potential.", "x": [["A) Viral-induced benign ulcer", "The biopsy proof of invasion excludes any benign process."], ["C) Basal cell carcinoma variant with pearly borders", "BCC shows basaloid islands and pearly borders, not keratinocyte invasion in a scar."], ["D) Stage IV pressure ulcer", "Pressure ulcer is a non-neoplastic wound due to immobility, not scar-site carcinoma."]]}, {"n": 26, "s": "A 19-year-old has multiple inflammatory papules and pustules on the face and back, without nodules or scars. Which oral agent is the appropriate first-line therapy?", "o": [["A", "Isotretinoin as first-line"], ["B", "Doxycycline 100 mg BD for 3 months"], ["C", "Minocycline 1 g once daily"], ["D", "Co-trimoxazole"]], "c": ["B)", "Doxycycline 100 mg BD for 3 months"], "co": "Moderate papulopustular acne — oral doxycycline", "ct": "Interpretation", "w": "Moderate inflammatory acne (papules and pustules, no nodules) is treated with a tetracycline — doxycycline 100 mg BD for about 3 months — added to topical therapy.", "d": "Nodule-free inflammatory acne defines moderate severity; that is the doxycycline tier, not isotretinoin.", "t": "Severity ladder — nodules/scars push to isotretinoin; papulopustular-only stays on doxycycline.", "f": "Moderate acne → doxycycline 100 mg BD × 3 months; nodulocystic → isotretinoin.", "r": "Moderate inflammatory acne (papules and pustules, no nodules) is treated with a tetracycline — doxycycline 100 mg BD for about 3 months — added to topical therapy.", "x": [["A) Isotretinoin as first-line", "Isotretinoin is reserved for severe nodulocystic acne or treatment failure — not first-line here."], ["C) Minocycline 1 g once daily", "Minocycline dose is 50-100 mg BD (not 1 g daily) and is a second-line tetracycline option."], ["D) Co-trimoxazole", "Co-trimoxazole is not standard first-line acne therapy."]]}, {"n": 27, "s": "A 28-year-old man gets recurrent \"cold sores\" on his lips triggered by sunlight. During the latent phase, where does the virus persist?", "o": [["A", "Trigeminal ganglion"], ["B", "Sacral dorsal root ganglion"], ["C", "Thoracic dorsal root ganglion"], ["D", "Trigeminal nucleus in the brainstem"]], "c": ["A)", "Trigeminal ganglion"], "co": "HSV-1 latency — trigeminal ganglion", "ct": "Recall", "w": "HSV-1 remains latent in the trigeminal ganglion, reactivating as orofacial cold sores; HSV-2 instead enters the sacral ganglion for genital disease.", "d": "Orofacial HSV-1 selectively targets the trigeminal ganglion — the stem only mentions lip lesions.", "t": "Ganglion map — HSV-1 trigeminal vs HSV-2 sacral vs VZV thoracic; do not swap.", "f": "Latency map: HSV-1 → trigeminal ganglion; HSV-2 → sacral; VZV → dorsal root ganglia.", "r": "HSV-1 remains latent in the trigeminal ganglion, reactivating as orofacial cold sores; HSV-2 instead enters the sacral ganglion for genital disease.", "x": [["B) Sacral dorsal root ganglion", "Sacral ganglion is the HSV-2 latency site for genital herpes."], ["C) Thoracic dorsal root ganglion", "Thoracic dorsal root ganglia hold varicella-zoster, not HSV-1."], ["D) Trigeminal nucleus in the brainstem", "Latency is in the peripheral sensory ganglion, not the brainstem nucleus."]]}, {"n": 28, "s": "A patient with dermatitis herpetiformis asks which treatment relieves the itching most rapidly while she prepares to commit to a long-term gluten-free diet. Which agent gives a dramatic response within 48 hours?", "o": [["A", "Cetirizine"], ["B", "Dapsone"], ["C", "Oral prednisolone"], ["D", "Acyclovir"]], "c": ["B)", "Dapsone"], "co": "Dermatitis herpetiformis — dapsone response within 48 h", "ct": "Recall", "w": "Dapsone produces a dramatic improvement in DH itching within 48 hours; long-term control relies on the gluten-free diet.", "d": "\"Dramatic response within 48 hours\" is the exam phrase attached to dapsone in DH.", "t": "Phrase-lock — \"dramatic within 48 hours\" + DH = dapsone, every time.", "f": "DH: itch responds to dapsone in 48 h; GFD is the long-term therapy.", "r": "Dapsone produces a dramatic improvement in DH itching within 48 hours; long-term control relies on the gluten-free diet.", "x": [["A) Cetirizine", "Antihistamines blunt itch generally but do not give the dramatic 48-h DH response."], ["C) Oral prednisolone", "Steroids are not first-line for DH; dapsone is."], ["D) Acyclovir", "Acyclovir is an antiviral — irrelevant to DH."]]}, {"n": 29, "s": "A 45-year-old woman has painful oral erosions for weeks, then flaccid skin blisters over the trunk. Nikolsky sign is positive; biopsy shows acantholysis just above the basal layer with intact basal cells (tombstone row). Which diagnosis best fits?", "o": [["A", "Bullous pemphigoid"], ["B", "Dermatitis herpetiformis"], ["C", "Erythema multiforme"], ["D", "Pemphigus vulgaris"]], "c": ["D)", "Pemphigus vulgaris"], "co": "Pemphigus vulgaris — oral-first, acantholysis above basal layer", "ct": "Interpretation", "w": "Oral erosions as the first sign, flaccid blisters, positive Nikolsky, and suprabasal acantholysis with a tombstone row of basal cells are the pemphigus vulgaris signature.", "d": "Every clue sits in one camp: oral first + flaccid + Nikolsky positive + suprabasal acantholysis = PV.", "t": "Clue pile-up — oral-first + tombstone basal row is PV, not the tense-blister mimics.", "f": "PV: suprabasal acantholysis (tombstone row) + positive Nikolsky; BP: subepidermal + negative Nikolsky.", "r": "Oral erosions as the first sign, flaccid blisters, positive Nikolsky, and suprabasal acantholysis with a tombstone row of basal cells are the pemphigus vulgaris signature.", "x": [["A) Bullous pemphigoid", "Bullous pemphigoid gives tense blisters, negative Nikolsky, subepidermal split, elderly patients."], ["B) Dermatitis herpetiformis", "Dermatitis herpetiformis is pruritic grouped vesicles on extensors with granular IgA."], ["C) Erythema multiforme", "Erythema multiforme has target lesions, no acantholysis."]]}, {"n": 30, "s": "An 8-year-old boy develops the sudden onset of many small \"raindrop\" erythematous scaly papules over the trunk, 2 weeks after a sore throat. Which psoriasis subtype best fits?", "o": [["A", "Plaque psoriasis"], ["B", "Inverse psoriasis"], ["C", "Erythrodermic psoriasis"], ["D", "Guttate psoriasis"]], "c": ["D)", "Guttate psoriasis"], "co": "Guttate psoriasis — strep-triggered raindrop papules", "ct": "Interpretation", "w": "Guttate psoriasis presents as raindrop-like papules on the trunk in children/young adults, typically 1-3 weeks after streptococcal pharyngitis.", "d": "Age + \"raindrop\" papules + recent sore throat are the guttate signature.", "t": "Subtype map — know which psoriasis fires after strep (guttate) vs on the extensors (plaque).", "f": "Guttate psoriasis: child + strep → raindrop papules; plaque psoriasis: adult + extensor silvery scale.", "r": "Guttate psoriasis presents as raindrop-like papules on the trunk in children/young adults, typically 1-3 weeks after streptococcal pharyngitis.", "x": [["A) Plaque psoriasis", "Plaque psoriasis (90%) shows thick silvery scale on extensors, not acute raindrops."], ["B) Inverse psoriasis", "Inverse psoriasis is flexural with minimal scale, driven by friction/obesity."], ["C) Erythrodermic psoriasis", "Erythrodermic psoriasis covers >90% BSA and is a medical emergency."]]}, {"n": 31, "s": "During a cholera outbreak, the number of new cases reported per week doubles every 3 days. On day 0 there were 25 cases. If this pattern continues, approximately how many cases will there be after 12 days?", "o": [["A", "100"], ["B", "200"], ["C", "400"], ["D", "800"]], "c": ["C)", "400"], "co": "Epidemic doubling time calculation", "ct": "Interpretation (doubling-time arithmetic)", "w": "With a doubling time of 3 days, cases double at days 3, 6, 9 and 12: 25 → 50 → 100 → 200 → 400. Four doublings give 25 × 2⁴ = 400 cases.", "d": "12 days ÷ 3-day doubling = 4 doublings; 25 × 2⁴ = 400", "t": "Unit/Number - counting the doublings (25 → 50 → 100 → 200 → 400)", "f": "Doubling time: divide the observation window by the doubling time, then apply 2ⁿ to the starting count", "r": "Cases = starting count × 2^(window ÷ doubling time); 25 × 2⁴ = 400", "x": [["A) 100", "100 reflects only two doublings, as if the window were 6 days rather than 12."], ["B) 200", "200 reflects only three doublings (25 × 2³); the 12-day window allows four doublings."], ["D) 800", "800 reflects five doublings (25 × 2⁵), one more than the window allows."]]}, {"n": 32, "s": "An asymptomatic 3-year-old child shares a home with his grandfather, who has smear-positive pulmonary tuberculosis. The child's chest X-ray is normal. What is the most appropriate management?", "o": [["A", "Give BCG vaccination immediately"], ["B", "Give isoniazid preventive therapy for 6-9 months"], ["C", "Start full four-drug anti-tuberculosis treatment"], ["D", "No action is needed because the child is asymptomatic"]], "c": ["B)", "Give isoniazid preventive therapy for 6-9 months"], "co": "Isoniazid preventive therapy for child contacts of smear-positive TB", "ct": "Interpretation/Analysis (preventive vs therapeutic decision)", "w": "Children under 5 who are household contacts of a smear-positive TB case are at high risk of infection and severe disease. After active TB is excluded (normal CXR), isoniazid preventive therapy for 6-9 months is indicated.", "d": "Child under 5 + household contact of smear-positive TB + normal CXR → INH preventive therapy (active TB excluded)", "t": "Treatment ladder - preventive therapy (INH alone) chosen before full anti-TB treatment is justified", "f": "Child < 5 + smear-positive household contact = INH preventive therapy 6-9 months after excluding active TB", "r": "INH preventive therapy (6-9 months) for children < 5 in household contact with smear-positive TB once active disease is excluded", "x": [["A) Give BCG vaccination immediately", "BCG is given in infancy for general protection; it is not the post-exposure measure for an older household contact."], ["C) Start full four-drug anti-tuberculosis treatment", "Full four-drug treatment is for active TB - the child's CXR is normal and he is asymptomatic."], ["D) No action is needed because the child is asymptomatic", "Asymptomatic contacts still merit chemoprophylaxis; inaction risks progression to severe disease."]]}, {"n": 33, "s": "A rapid diagnostic test for typhoid was evaluated against blood culture in 2,000 febrile patients. Of 300 patients with culture-confirmed typhoid, 270 tested positive. Of 1,700 patients without typhoid, 1,530 tested negative. What is the negative predictive value (NPV) of this test?", "o": [["A", "90.0%"], ["B", "61.4%"], ["C", "98.1%"], ["D", "85.0%"]], "c": ["C)", "98.1%"], "co": "Negative predictive value from a 2×2 table", "ct": "Interpretation (2×2 table arithmetic)", "w": "NPV is the proportion of test-negative patients who truly do not have the disease: 1,530 true negatives ÷ 1,560 total test-negatives = 98.1%. The 30 false negatives are the 300 diseased minus the 270 detected.", "d": "NPV = true negatives ÷ all test-negatives = 1,530 ÷ (1,530 + 30) = 98.1%", "t": "Pattern recognition - locating the NPV cell (d ÷ (c + d)) instead of PPV or sensitivity", "f": "NPV = d/(c+d); PPV = a/(a+b); sensitivity = a/(a+c); specificity = d/(b+d)", "r": "NPV = true negatives ÷ (true negatives + false negatives)", "x": [["A) 90.0%", "90.0% is the sensitivity (270 ÷ 300), not the NPV."], ["B) 61.4%", "61.4% is the PPV (270 ÷ 440 test-positives) - the reciprocal error of using the wrong column."], ["D) 85.0%", "85.0% has no basis in this table; it is not derived from any of the four index calculations."]]}, {"n": 34, "s": "In a randomized controlled trial, a new antihypertensive drug is compared with placebo. The primary outcome is the mean fall in systolic blood pressure, measured in each of the two groups. Which statistical test is most appropriate to compare the two group means?", "o": [["A", "Chi-square test"], ["B", "Paired t-test"], ["C", "Independent (unpaired) t-test"], ["D", "Pearson correlation coefficient"]], "c": ["C)", "Independent (unpaired) t-test"], "co": "Selection of the appropriate test of significance for two independent means", "ct": "Recall (test selection rules)", "w": "The outcome is a continuous variable compared between two independent groups (drug vs placebo), so the independent (unpaired) t-test is appropriate.", "d": "Continuous outcome (mean BP fall) + two independent groups → unpaired t-test", "t": "Negative discrimination - chi-square is tempting but tests proportions, not means", "f": "Two independent groups + continuous outcome = unpaired t-test; proportions = chi-square; before-after same subjects = paired t-test", "r": "Comparing two independent group means of a continuous variable → independent t-test", "x": [["A) Chi-square test", "Chi-square compares proportions or categories, not continuous means."], ["B) Paired t-test", "Paired t-test is for before-after or matched measurements in the same subjects."], ["D) Pearson correlation coefficient", "Correlation examines the relationship between two continuous variables, not a difference between groups."]]}, {"n": 35, "s": "According to Pakistan's Expanded Programme on Immunization (EPI), at what age is the first dose of the measles-containing vaccine (MR-1) scheduled?", "o": [["A", "6 months"], ["B", "9 months"], ["C", "12 months"], ["D", "15 months"]], "c": ["B)", "9 months"], "co": "EPI schedule - timing of first measles dose", "ct": "Recall (EPI schedule)", "w": "In Pakistan's EPI schedule, the first measles-containing vaccine dose (MR-1) is given at 9 months, with a second dose (MR-2) at 15 months. The 9-month timing balances maternal antibody decline with early measles risk.", "d": "EPI Pakistan: MR-1 at 9 months, MR-2 at 15 months", "t": "Guideline Version - 12 months (other schedules) swapped for the EPI 9-month dose", "f": "EPI measles: MR-1 at 9 months, MR-2 at 15 months", "r": "EPI: MR-1 at 9 months, MR-2 at 15 months", "x": [["A) 6 months", "6 months is too early - maternal antibodies still interfere and immunogenicity is reduced."], ["C) 12 months", "12 months is the schedule in several high-income countries (MMR at 12-15 months), not the EPI."], ["D) 15 months", "15 months is the timing of the EPI second dose (MR-2), not the first."]]}, {"n": 36, "s": "A nurse sustains a deep needlestick injury while drawing blood from a patient known to be HIV-positive with a high viral load. When should HIV post-exposure prophylaxis (PEP) be started?", "o": [["A", "Start PEP immediately (ideally within hours, and not later than 72 hours) and continue for 28 days"], ["B", "Wait for repeat confirmatory HIV testing of the source patient, then decide"], ["C", "Start PEP only if the nurse tests HIV-positive at 3 months"], ["D", "Give a single antiretroviral drug for 7 days"]], "c": ["A)", "Start PEP immediately (ideally within hours, and not later than 72 hours) and continue for 28 days"], "co": "HIV post-exposure prophylaxis timing and duration", "ct": "Analysis/synthesis (occupational exposure management)", "w": "Occupational HIV PEP should begin as soon as possible (ideally within 2 hours) and no later than 72 hours after exposure, with a 28-day course of antiretrovirals. Waiting for the source's confirmatory test or for the worker to seroconvert forfeits the window of effectiveness.", "d": "Deep parenteral exposure to a high-viral-load source → start PEP immediately, within 72 h, 28 days", "t": "Priority inversion - waiting for confirmatory serology before starting PEP", "f": "Occupational HIV exposure = start PEP within hours (max 72 h), 28-day course; baseline and follow-up HIV testing of the worker", "r": "HIV PEP: start within 72 h (ideally < 2 h), continue 28 days; do not wait for source confirmation", "x": [["B) Wait for repeat confirmatory HIV testing of the source patient, then decide", "Waiting for the source's repeat serology delays PEP beyond the effective window."], ["C) Start PEP only if the nurse tests HIV-positive at 3 months", "Starting PEP only after the worker seroconverts is pointless - PEP prevents, it does not treat established infection."], ["D) Give a single antiretroviral drug for 7 days", "A single drug for 7 days is inadequate; standard PEP is a combination regimen for 28 days."]]}, {"n": 37, "s": "A district hospital reports 15 cases of acute watery diarrhea in one week, whereas the area usually records 2-3 cases per week. Following the standard outbreak investigation sequence, what is the FIRST step?", "o": [["A", "Immediately implement control measures before anything else"], ["B", "Confirm the existence of an outbreak by comparing current and expected incidence"], ["C", "Start an analytic (case-control) study of the suspected food source"], ["D", "Analyze all stool samples in the laboratory before investigating"]], "c": ["B)", "Confirm the existence of an outbreak by comparing current and expected incidence"], "co": "Outbreak investigation - establishing the existence of an outbreak", "ct": "Analysis/synthesis (investigation sequence)", "w": "The first task in an outbreak investigation is to establish that an outbreak truly exists by comparing the current number of cases with the expected (baseline) incidence. Only after confirming the outbreak are descriptive, then analytic, studies undertaken - while early control measures may run in parallel.", "d": "Compare observed cases with the expected baseline to confirm an outbreak before descriptive and analytic steps", "t": "Investigation hierarchy - analytic study and mass control attempted before confirming the outbreak", "f": "Outbreak steps: confirm existence (vs baseline) → verify diagnosis → descriptive → hypothesis → analytic → control", "r": "Confirm the existence of an outbreak (observed vs expected incidence) before analytic investigation", "x": [["A) Immediately implement control measures before anything else", "Control measures may start early and in parallel, but confirming the outbreak is the recognized first investigative step."], ["C) Start an analytic (case-control) study of the suspected food source", "The analytic (case-control) study comes later in the sequence, after descriptive epidemiology generates hypotheses."], ["D) Analyze all stool samples in the laboratory before investigating", "Laboratory confirmation is part of verifying the diagnosis after the outbreak's existence is established."]]}, {"n": 38, "s": "A district's population pyramid has a very broad base that narrows steeply through successively higher age groups. Which population structure does this pattern represent?", "o": [["A", "An ageing population with low fertility"], ["B", "A youthful population with high fertility and high mortality at younger ages"], ["C", "A stationary population with stable birth and death rates"], ["D", "A contracting population with net emigration of adults"]], "c": ["B)", "A youthful population with high fertility and high mortality at younger ages"], "co": "Population pyramid interpretation", "ct": "Interpretation (pyramid shape → demographic structure)", "w": "A broad-based, steeply narrowing pyramid shows high proportions of children and rapid attrition with age - the classic signature of high fertility and high mortality at younger ages, typical of developing (growing) populations.", "d": "Broad base = many children (high fertility); steep narrowing = high mortality in young ages - typical of developing populations", "t": "Pattern recognition - broad base misread as an ageing population", "f": "Broad base + steep narrowing = young, growing population (high fertility); narrow base = ageing", "r": "Broad-based pyramid = high birth rate, high childhood mortality, rapid growth", "x": [["A) An ageing population with low fertility", "Ageing populations have narrow or inverted bases with bulging older age groups - the opposite shape."], ["C) A stationary population with stable birth and death rates", "A stationary population shows nearly vertical sides with a relatively even spread across age groups."], ["D) A contracting population with net emigration of adults", "Adult emigration removes the working-age bulge; it does not produce a broad, fast-tapering pyramid."]]}, {"n": 39, "s": "Which statement correctly describes the infant mortality rate (IMR)?", "o": [["A", "It includes stillbirths in its numerator"], ["B", "It is the number of deaths under 1 year of age per 1,000 live births in a year"], ["C", "It excludes all deaths that occur in the first month of life"], ["D", "It is expressed per 100,000 live births"]], "c": ["B)", "It is the number of deaths under 1 year of age per 1,000 live births in a year"], "co": "Infant mortality rate definition", "ct": "Recall (indicator definition)", "w": "The infant mortality rate is the number of deaths under one year of age per 1,000 live births in a year. Stillbirths are fetal deaths, not live births, so they are excluded from both the numerator and the denominator.", "d": "Deaths under 1 year ÷ 1,000 live births; stillbirths are not live births and are excluded", "t": "Age-appropriate differential - stillbirths (not live births) are excluded from the IMR", "f": "IMR = deaths < 1 year per 1,000 live births; neonatal deaths (first 28 days) are included", "r": "IMR = deaths under 1 year ÷ live births × 1,000; stillbirths excluded", "x": [["A) It includes stillbirths in its numerator", "Stillbirths are fetal deaths - not live births - and are excluded from the IMR."], ["C) It excludes all deaths that occur in the first month of life", "Deaths in the first month (neonatal deaths) are counted in the IMR; neonatal mortality is a component of it."], ["D) It is expressed per 100,000 live births", "100,000 live births is the denominator of the maternal mortality ratio; the IMR uses 1,000."]]}, {"n": 40, "s": "Insecticide-treated bed nets are the cornerstone of malaria vector control in endemic regions because the principal vector:", "o": [["A", "Bites during the day, mainly outdoors"], ["B", "Bites at night, mainly indoors"], ["C", "Breeds only in polluted stagnant water"], ["D", "Transmits the parasite only in urban settings"]], "c": ["B)", "Bites at night, mainly indoors"], "co": "Malaria vector behavior and rationale for ITNs", "ct": "Interpretation (vector ecology applied to control strategy)", "w": "Anopheles mosquitoes (the malaria vector) bite mainly at night, indoors, which is exactly when insecticide-treated nets protect the sleeper. This nocturnal indoor biting behavior is why ITNs are the most effective personal protection in endemic areas.", "d": "Female Anopheles mosquitoes bite between dusk and dawn indoors → bed nets cover the transmission window", "t": "Organism homogeneity - Anopheles (night, indoor) exchanged with Aedes (day, outdoor) behavior", "f": "Anopheles = night, indoor biter (ITNs); Aedes = day biter (source reduction)", "r": "Female Anopheles bites at night indoors → ITNs are the cornerstone of vector control", "x": [["A) Bites during the day, mainly outdoors", "Daytime outdoor biting describes Aedes mosquitoes (dengue), not Anopheles; it would make bed nets useless."], ["C) Breeds only in polluted stagnant water", "Anopheles breeds in clean (often slow-moving) water; polluted-water breeding characterizes Culex."], ["D) Transmits the parasite only in urban settings", "Malaria is predominantly rural/peri-urban; transmission is not confined to urban settings."]]}, {"n": 41, "s": "A health facility refrigerator malfunctions overnight and the vaccine vials are exposed to -5°C. Which vaccine is MOST likely to have been irreversibly damaged by freezing?", "o": [["A", "Oral polio vaccine"], ["B", "Measles (MR) vaccine"], ["C", "Hepatitis B vaccine"], ["D", "BCG vaccine"]], "c": ["C)", "Hepatitis B vaccine"], "co": "Cold chain - freeze-sensitive vs freeze-tolerant vaccines", "ct": "Interpretation (cold chain breach consequences)", "w": "Hepatitis B vaccine is an aluminum-adsorbed vaccine whose potency is irreversibly lost when frozen (adjuvant gel collapse). Lyophilized live vaccines such as OPV, measles (MR), and BCG tolerate freezing but are damaged by heat.", "d": "Aluminum-adjuvanted vaccines (HepB, DTP) are destroyed by freezing; lyophilized live vaccines (OPV, measles, BCG) tolerate it", "t": "Iatrogenic trap - a storage error silently destroying vaccine potency without visible change", "f": "Freeze-sensitive = HepB/DTP/pentavalent/IPV; freeze-tolerant = OPV/measles/BCG; store at +2 to +8 °C", "r": "Freezing destroys aluminum-adjuvanted vaccines (HepB, DTP); live lyophilized vaccines tolerate freezing but not heat", "x": [["A) Oral polio vaccine", "OPV is freeze-tolerant - it withstands freezing but loses potency in heat - so it is not the damaged vaccine here."], ["B) Measles (MR) vaccine", "Measles vaccine is lyophilized and freeze-stable; heat, not freezing, is its enemy."], ["D) BCG vaccine", "BCG is also lyophilized and tolerates freezing, unlike adsorbed vaccines."]]}, {"n": 42, "s": "Using occupational health records from 1990, investigators classify 3,000 chemical plant workers as exposed or unexposed to benzene, then link these records to the national cancer registry up to 2025 to compare cancer incidence. What is the study design?", "o": [["A", "Prospective cohort study"], ["B", "Retrospective cohort study"], ["C", "Case-control study"], ["D", "Cross-sectional study"]], "c": ["B)", "Retrospective cohort study"], "co": "Retrospective (historical) cohort study identification", "ct": "Analysis/synthesis (design recognition from methodological clues)", "w": "The cohort is defined by exposure documented in 1990 historical records and followed forward in time for outcomes recorded in the registry. Because both exposure and cohort assembly lie in the past, this is a retrospective (historical) cohort study - exposure precedes outcome, so it is still a cohort, not a case-control design.", "d": "Exposure defined from historical records, cohort assembled in the past, outcomes followed forward via registry = retrospective cohort", "t": "Overthinking - existing records suggest case-control, but the cohort follows exposure to outcome in time order", "f": "Historical records + forward follow-up for outcomes = retrospective cohort; outcomes first, exposure recalled = case-control", "r": "Retrospective cohort: exposure from past records, outcomes in the present; time order exposure → outcome preserved", "x": [["A) Prospective cohort study", "A prospective cohort defines exposure now and follows participants into the future; here exposure is taken from 1990 records."], ["C) Case-control study", "Case-control studies select participants by outcome and look back for exposure - the opposite time order."], ["D) Cross-sectional study", "Cross-sectional studies measure exposure and outcome at the same time; they cannot establish this sequence."]]}, {"n": 43, "s": "A health authority is deciding whether to introduce a population-wide screening programme. Which condition is most suitable for screening?", "o": [["A", "A common cancer with a long detectable preclinical phase and effective treatment at early stages"], ["B", "A rapidly fatal cancer for which no effective treatment exists"], ["C", "A very rare disease with an inexpensive test"], ["D", "A mild self-limiting infection that resolves without treatment"]], "c": ["A)", "A common cancer with a long detectable preclinical phase and effective treatment at early stages"], "co": "Suitability criteria for a screening programme", "ct": "Analysis/synthesis (applying screening principles)", "w": "Suitable screening targets are important health problems with a recognizable latent or early stage, a valid test, and treatment that is more effective when started early. A fatal untreatable disease cannot be helped by early detection.", "d": "Screening is worthwhile when the disease is common, has a detectable latent phase, and early treatment improves outcome", "t": "Partial Truth - severity alone (a fatal cancer) does not make a condition screenable", "f": "Screenable = treatable early + long preclinical phase; 'severe but untreatable' fails the criteria", "r": "Screening is justified when early detection changes outcome (treatable disease with a detectable preclinical phase)", "x": [["B) A rapidly fatal cancer for which no effective treatment exists", "Without effective early treatment, detecting a rapidly fatal cancer early does not improve survival - screening cannot help."], ["C) A very rare disease with an inexpensive test", "Screening a very rare disease produces many false positives relative to true cases and is inefficient."], ["D) A mild self-limiting infection that resolves without treatment", "A self-limiting infection with no morbidity benefit does not justify screening a whole population."]]}, {"n": 44, "s": "In a case-control study, 200 patients with colorectal cancer and 200 matched healthy controls are interviewed about their diet over the past 10 years. Compared with a cohort study, what is the main weakness of this design?", "o": [["A", "Loss to follow-up"], ["B", "Recall bias"], ["C", "Inability to study rare diseases"], ["D", "High cost for a small number of outcomes"]], "c": ["B)", "Recall bias"], "co": "Recall bias as the principal limitation of case-control studies", "ct": "Interpretation (bias attribution to study design)", "w": "Case-control studies rely on recalling past exposure, and cases may recall (or report) exposures differently from controls - this differential misclassification is recall bias, the design's main weakness. Loss to follow-up is a cohort problem; case-control studies are efficient for rare diseases.", "d": "Retrospective recall of past exposure by cases and controls → differential misclassification (recall bias)", "t": "Clinical Mimic - attrition (a cohort bias) wrongly applied to a case-control design", "f": "Case-control → recall bias; cohort → loss to follow-up", "r": "Case-control studies are vulnerable to recall bias (differential recall between cases and controls)", "x": [["A) Loss to follow-up", "Loss to follow-up is the classic weakness of cohort studies, where participants are tracked over time."], ["C) Inability to study rare diseases", "Case-control studies are ideal for rare diseases - the opposite of this claim."], ["D) High cost for a small number of outcomes", "They are relatively quick and inexpensive; selecting many outcomes per study is their strength."]]}, {"n": 45, "s": "A team surveys a town of 5,000 adults on a single day and finds that 85 currently have diabetes mellitus. Which epidemiological measure does the figure of 85/5,000 represent?", "o": [["A", "Incidence rate"], ["B", "Point prevalence"], ["C", "Attack rate"], ["D", "Cumulative incidence"]], "c": ["B)", "Point prevalence"], "co": "Point prevalence vs incidence", "ct": "Interpretation (measure classification)", "w": "The survey counts all existing cases of diabetes in the population on one day, giving point prevalence (85/5,000). Incidence measures NEW cases arising over a period of time, not existing cases at a single time point.", "d": "Existing cases counted on a single day ÷ population at that time = point prevalence", "t": "Synonym Swap - existing cases (prevalence) exchanged for new cases (incidence)", "f": "One-day snapshot of existing cases = point prevalence; new cases over time ÷ population at risk = incidence", "r": "Prevalence = existing cases at a point in time ÷ population; incidence = new cases over a period ÷ population at risk", "x": [["A) Incidence rate", "Incidence rate measures new cases developing over a defined period, not existing cases on one day."], ["C) Attack rate", "Attack rate applies to the proportion of an exposed group developing illness during an outbreak."], ["D) Cumulative incidence", "Cumulative incidence requires following a population over time for new events - not a one-day snapshot."]]}, {"n": 46, "s": "The maternal mortality ratio (MMR) is conventionally expressed as the number of maternal deaths per how many live births?", "o": [["A", "1,000 live births"], ["B", "10,000 live births"], ["C", "100,000 live births"], ["D", "100,000 women of reproductive age"]], "c": ["C)", "100,000 live births"], "co": "Maternal mortality ratio denominator", "ct": "Recall (indicator definition)", "w": "The maternal mortality ratio is defined as maternal deaths per 100,000 live births. The denominator is live births, not women of reproductive age.", "d": "MMR = maternal deaths per 100,000 live births", "t": "Unit/Number - the 100,000 denominator is the classic slip (vs 1,000 for IMR)", "f": "MMR per 100,000 live births; IMR per 1,000 live births", "r": "MMR = maternal deaths ÷ live births × 100,000", "x": [["A) 1,000 live births", "1,000 live births is the denominator of the infant mortality rate, not the MMR."], ["B) 10,000 live births", "10,000 is not used for either indicator; the MMR uses 100,000."], ["D) 100,000 women of reproductive age", "Women of reproductive age form the denominator of the maternal mortality RATE, not the ratio."]]}, {"n": 47, "s": "In a randomized controlled trial of a weight-loss drug, 18% of participants in the intervention group never took the study drug. The primary analysis includes all randomized participants in the groups to which they were assigned. What is this analysis called?", "o": [["A", "Per-protocol analysis"], ["B", "Intention-to-treat analysis"], ["C", "On-treatment analysis"], ["D", "Subgroup analysis"]], "c": ["B)", "Intention-to-treat analysis"], "co": "Intention-to-treat analysis in RCTs", "ct": "Analysis/synthesis (trial methodology interpretation)", "w": "Intention-to-treat analysis includes every randomized participant in the group to which they were assigned, regardless of adherence or withdrawal. It preserves the benefit of randomization and gives a pragmatic estimate of real-world effectiveness.", "d": "Analyzing all randomized participants in their assigned groups, regardless of adherence = intention-to-treat", "t": "Partial Truth - per-protocol analysis seems 'cleaner' but breaks randomization", "f": "ITT = analyze as randomized; per-protocol excludes non-adherers and risks bias", "r": "ITT analysis includes all randomized participants in their assigned groups, preserving randomization", "x": [["A) Per-protocol analysis", "Per-protocol analysis excludes participants who did not adhere, losing the balance randomization provided."], ["C) On-treatment analysis", "On-treatment analysis groups by the treatment actually received, which also breaks randomization."], ["D) Subgroup analysis", "Subgroup analysis examines subsets of participants; it is not the primary analysis strategy."]]}, {"n": 48, "s": "The government passes legislation making salt iodization compulsory across the country to prevent iodine deficiency disorders in the population. This measure is an example of which level of prevention?", "o": [["A", "Primordial prevention"], ["B", "Primary prevention"], ["C", "Secondary prevention"], ["D", "Tertiary prevention"]], "c": ["A)", "Primordial prevention"], "co": "Levels of prevention - primordial vs primary", "ct": "Interpretation (prevention level classification)", "w": "Primordial prevention targets the population as a whole through policy and social measures (such as salt iodization legislation) to prevent risk factors for disease from emerging in the first place. Primary prevention reduces individual exposure to established risk factors.", "d": "Population-level, policy-driven action to prevent the emergence of risk factors before disease exists = primordial prevention", "t": "Synonym Swap - primordial (societal policy) exchanged for primary (individual-level action)", "f": "Policy/law targeting whole populations = primordial; individual risk-reduction measures = primary", "r": "Primordial prevention = population-level measures preventing risk factors before they appear (legislation, policy)", "x": [["B) Primary prevention", "Primary prevention acts on individuals to reduce established risk factors (e.g. immunization, smoking cessation)."], ["C) Secondary prevention", "Secondary prevention is early detection and treatment of existing disease (screening)."], ["D) Tertiary prevention", "Tertiary prevention limits disability and rehabilitates patients with established disease."]]}, {"n": 49, "s": "In a case-control study of pancreatic cancer and coffee drinking, 80 of 100 cases and 60 of 100 controls reported drinking coffee. Which measure of association is calculated, and what is its value?", "o": [["A", "Relative risk of 1.33"], ["B", "Odds ratio of 1.33"], ["C", "Odds ratio of 2.67"], ["D", "Relative risk of 2.67"]], "c": ["C)", "Odds ratio of 2.67"], "co": "Odds ratio calculation in a case-control study", "ct": "Analysis/synthesis (measure selection and computation)", "w": "In a case-control study, participants are selected by outcome, so incidence cannot be measured and relative risk cannot be computed. The odds ratio is calculated as ad/bc = (80 × 40)/(20 × 60) = 3,200/1,200 = 2.67.", "d": "Case-control data yield only the odds ratio: OR = (80 × 40) ÷ (20 × 60) = 2.67", "t": "'What NOT to do' - computing a relative risk from case-control data", "f": "Case-control → OR = ad/bc; RR requires incidence (cohort/intervention studies)", "r": "OR = ad/bc; in case-control studies the OR approximates the RR only for rare diseases", "x": [["A) Relative risk of 1.33", "Relative risk cannot be calculated from a case-control study - no incidence data exist."], ["B) Odds ratio of 1.33", "1.33 is the crude case/control exposure ratio (80/60), not the odds ratio."], ["D) Relative risk of 2.67", "2.67 is the correct numeric value but it is an odds ratio, not a relative risk."]]}, {"n": 50, "s": "A multicenter trial reports a p-value of 0.03 for its primary outcome. Which statement is the correct interpretation of this p-value?", "o": [["A", "There is a 3% probability that the null hypothesis is true"], ["B", "There is a 97% probability that the treatment is effective"], ["C", "If the null hypothesis were true, the probability of obtaining results at least this extreme is 3%"], ["D", "The result is clinically significant because it is below 0.05"]], "c": ["C)", "If the null hypothesis were true, the probability of obtaining results at least this extreme is 3%"], "co": "Correct interpretation of the p-value", "ct": "Interpretation (p-value semantics)", "w": "The p-value is the probability of observing results at least as extreme as those obtained, assuming the null hypothesis is true. It is not the probability that the null is true, nor the probability that the treatment works.", "d": "p = probability of the data (or more extreme) assuming the null is true, not the probability that the null is true", "t": "Opposite - p-value read as the probability of the null hypothesis", "f": "p = P(data | H₀ true); never P(H₀ true) or P(treatment works)", "r": "p-value = probability of the observed (or more extreme) data if the null hypothesis is true", "x": [["A) There is a 3% probability that the null hypothesis is true", "This is the posterior probability of the null - a common misconception; p does not measure how likely the null is."], ["B) There is a 97% probability that the treatment is effective", "The p-value says nothing about the probability that a treatment is effective."], ["D) The result is clinically significant because it is below 0.05", "Statistical significance (p < 0.05) does not equal clinical significance."]]}, {"n": 51, "s": "After monsoon flooding contaminated the shallow wells of a village, 40 children and young adults developed jaundice over 2 weeks. None had blood transfusions, injections, or tattoos. Which is the most likely mode of transmission?", "o": [["A", "Sexual contact"], ["B", "Parenteral (blood-borne)"], ["C", "Fecal-oral"], ["D", "Vertical (mother to child)"]], "c": ["C)", "Fecal-oral"], "co": "Hepatitis E outbreak - fecal-oral transmission", "ct": "Analysis/synthesis (outbreak clue pattern)", "w": "An outbreak of jaundice in children and young adults linked to contaminated drinking water after flooding, with no parenteral risk factors, points to hepatitis E (endemic in South Asia), which spreads by the fecal-oral route.", "d": "Flood + contaminated water + children/young adults + no parenteral risk = hepatitis E (fecal-oral)", "t": "Clinical Mimic - HEV jaundice mistaken for blood-borne hepatitis B", "f": "Water-borne jaundice outbreak = HEV/HAV (fecal-oral); HBV/HCV need parenteral exposure", "r": "Hepatitis E: water-borne, fecal-oral, mainly children and young adults, high mortality in pregnancy", "x": [["A) Sexual contact", "Sexual transmission is a route for HBV, not for water-borne HEV."], ["B) Parenteral (blood-borne)", "Parenteral transmission underlies HBV/HCV - absent here (no transfusions, injections, or tattoos)."], ["D) Vertical (mother to child)", "Vertical transmission occurs with HBV/HIV; it does not explain an outbreak across 40 children from a common water source."]]}, {"n": 52, "s": "A cohort study of regular exercise reports a relative risk (RR) of 0.6 for myocardial infarction in exercisers compared with sedentary adults. What is the correct interpretation?", "o": [["A", "Exercise reduces the risk of myocardial infarction by 60%"], ["B", "Exercise reduces the risk of myocardial infarction by 40%"], ["C", "Exercise increases the risk of myocardial infarction by 60%"], ["D", "Risk reduction cannot be interpreted from a relative risk"]], "c": ["B)", "Exercise reduces the risk of myocardial infarction by 40%"], "co": "Interpreting a protective relative risk", "ct": "Interpretation (RR less than 1)", "w": "An RR of 0.6 means exercisers have 60% of the risk of sedentary adults; the relative risk reduction is (1 - 0.6) = 0.4, i.e. a 40% reduction. The '60%' is the remaining risk, not the reduction.", "d": "RR < 1 = protective; risk reduction = (1 - RR) = 40%, not the remaining risk of 60%", "t": "Unit/Number - remaining risk (0.6) misread as the amount of risk reduction", "f": "RR of 0.6 = 40% risk reduction (1 - RR); never read the residual risk as the reduction", "r": "Protective RR: risk reduction = 1 - RR; RR 0.6 = 40% reduction", "x": [["A) Exercise reduces the risk of myocardial infarction by 60%", "60% is the residual risk (RR 0.6), not the reduction; the reduction is 1 - 0.6 = 40%."], ["C) Exercise increases the risk of myocardial infarction by 60%", "An RR below 1 indicates protection, not harm."], ["D) Risk reduction cannot be interpreted from a relative risk", "Relative risk is interpretable directly; the error would be in misreading the direction."]]}, {"n": 53, "s": "In a nutrition survey of children aged 6-59 months, a child has a weight-for-height Z-score of -3.4 and bilateral pitting edema. According to WHO criteria, this child has:", "o": [["A", "Stunting (chronic malnutrition)"], ["B", "Severe acute malnutrition"], ["C", "Moderate acute malnutrition"], ["D", "Isolated micronutrient deficiency"]], "c": ["B)", "Severe acute malnutrition"], "co": "Severe acute malnutrition - WHO anthropometric criteria", "ct": "Recall/Interpretation (WHZ cut-offs and edema)", "w": "By WHO criteria, severe acute malnutrition is defined by weight-for-height Z-score below -3 SD, MUAC below 11.5 cm, or bilateral pitting edema. This child meets two criteria (Z-score -3.4 and edema).", "d": "WHZ < -3 SD OR bilateral pitting edema = severe acute malnutrition", "t": "Severity under-recognition - SAM downgraded to moderate malnutrition or chronic stunting", "f": "SAM = WHZ < -3, MUAC < 11.5 cm, or edema; stunting = height-for-age (chronic), not WHZ", "r": "WHZ < -3 SD or bilateral pitting edema = severe acute malnutrition (SAM)", "x": [["A) Stunting (chronic malnutrition)", "Stunting is low height-for-age, reflecting chronic malnutrition; it is not diagnosed by weight-for-height or edema."], ["C) Moderate acute malnutrition", "Moderate acute malnutrition is WHZ between -3 and -2 SD without edema - this child's Z-score is worse."], ["D) Isolated micronutrient deficiency", "Edema plus severe wasting is a protein-energy malnutrition syndrome, not an isolated micronutrient problem."]]}, {"n": 54, "s": "A researcher records the monthly incomes (in thousand rupees) of 9 households in a village: 8, 10, 12, 12, 15, 16, 18, 20, 350. Which measure of central tendency best represents this distribution?", "o": [["A", "Mean (51.2)"], ["B", "Median (15)"], ["C", "Mode (12)"], ["D", "Range (342)"]], "c": ["B)", "Median (15)"], "co": "Choice of central tendency measure in skewed data", "ct": "Interpretation (outlier effect on summary measures)", "w": "The outlier of 350 pulls the mean to 51.2, which misrepresents the typical household. The median (15) is resistant to outliers and is the appropriate central-tendency measure for positively skewed data.", "d": "One extreme outlier (350) skews the mean upward; the median (15) stays robust", "t": "Synonym Swap - mean selected by reflex despite a skewed distribution", "f": "Skewed distribution or outliers = median; symmetric distribution = mean", "r": "Positively skewed data with outliers → median is the best measure of central tendency", "x": [["A) Mean (51.2)", "The mean (51.2) is inflated by the single 350 outlier and does not represent the typical household."], ["C) Mode (12)", "The mode (12) is the most frequent value but ignores the spread of the rest of the distribution."], ["D) Range (342)", "The range is a measure of dispersion, not central tendency."]]}, {"n": 55, "s": "During a dengue outbreak, health workers find Aedes aegypti larvae breeding in household water storage containers. Which intervention gives the most effective sustained vector control?", "o": [["A", "Insecticide fogging to kill adult mosquitoes"], ["B", "Source reduction by eliminating or covering breeding containers"], ["C", "Isolation of all febrile patients at home"], ["D", "Antibiotic prophylaxis for all household contacts"]], "c": ["B)", "Source reduction by eliminating or covering breeding containers"], "co": "Dengue vector control - source reduction", "ct": "Analysis/synthesis (vector control strategy)", "w": "Aedes aegypti is a day-biting domestic mosquito that breeds in clean water in household containers. Eliminating or covering these breeding sites (source reduction) attacks the larval stage and provides the most sustainable control; fogging only transiently reduces adult mosquitoes.", "d": "Aedes aegypti breeds in clean stagnant water in domestic containers → source reduction (container management) is the sustainable core measure", "t": "Treatment misdirection - fogging adults (a visible but short-lived measure) chosen over larval source reduction", "f": "Dengue control = source reduction of containers; fogging is a temporary adulticide", "r": "Source reduction (removing/covering water containers) is the most effective sustained dengue control", "x": [["A) Insecticide fogging to kill adult mosquitoes", "Fogging kills only flying adults and is short-lived; larvae in containers continue the cycle."], ["C) Isolation of all febrile patients at home", "Isolating febrile patients has little effect - dengue is mosquito-borne, not person-to-person."], ["D) Antibiotic prophylaxis for all household contacts", "Antibiotics have no role in a viral disease and cannot interrupt vector-borne transmission."]]}, {"n": 56, "s": "A 3-year-old boy drank kerosene stored in a soft-drink bottle and began coughing and gagging immediately. His mother says the child 'choked' on the liquid. The attending doctor explains that kerosene readily enters the airways during swallowing. Which physicochemical property of kerosene is primarily responsible for this aspiration hazard?", "o": [["A", "Alkaline pH that irritates the pharynx and triggers reflex inhalation"], ["B", "Low viscosity and low surface tension"], ["C", "High lipid solubility with rapid central nervous system penetration"], ["D", "High specific gravity causing it to sink and pool in the stomach"]], "c": ["B)", "Low viscosity and low surface tension"], "co": "Hydrocarbon (kerosene) poisoning — physicochemical basis of aspiration", "ct": "Interpretation (physical property translated into clinical risk)", "w": "Kerosene has a low viscosity and low surface tension, so a sip triggers coughing and gagging and the liquid flows readily into the tracheobronchial tree, producing chemical pneumonitis — the danger that makes gastric emptying hazardous.", "d": "Low viscosity + low surface tension allow kerosene to track into the trachea during swallowing; lipid solubility explains CNS depression, not aspiration", "t": "Partial Truth — high lipid solubility and volatility are real kerosene properties but explain CNS depression and fumes, not aspiration on swallowing", "f": "Choking + cough + fever after kerosene = chemical pneumonitis; never lavage, never induce vomiting", "r": "Low viscosity and low surface tension of kerosene promote aspiration during ingestion; supportive care, no gastric emptying", "x": [["A) Alkaline pH that irritates the pharynx and triggers reflex inhalation", "Kerosene is neutral, not alkaline; reflex inhalation is triggered by the physical properties of the liquid, not by its pH."], ["C) High lipid solubility with rapid central nervous system penetration", "High lipid solubility explains the central nervous system depression seen in hydrocarbon poisoning — it does not explain why the liquid is aspirated during swallowing."], ["D) High specific gravity causing it to sink and pool in the stomach", "High specific gravity is not a property of kerosene relevant here; kerosene is lighter than water and its density does not drive aspiration."]]}, {"n": 57, "s": "In a medicolegal examination, radiographs are used to estimate the age of an unidentified skeleton. Which epiphysis, being the last to unite in the body, indicates that the person had reached approximately 25 years of age?", "o": [["A", "The medial end of the clavicle"], ["B", "The lower end of the radius"], ["C", "The iliac crest"], ["D", "The head of the humerus"]], "c": ["A)", "The medial end of the clavicle"], "co": "Age estimation — ossification centres", "ct": "Recall (final epiphyseal union)", "w": "The medial (sternal) end of the clavicle is the last epiphysis in the body to unite, at about 23-25 years, so its fusion indicates the individual has passed approximately 25 years; all other major epiphyses close earlier.", "d": "Medial end of the clavicle unites last (about 25 years); the other centres close far earlier in the ossification timetable", "t": "Ossification chronology — the clavicle closes the series, and its timing is the anchor for the ~25-year estimate", "f": "Clavicle last (25); iliac crest 16-17; lower radius 18-19; humeral head 20", "r": "Medial clavicular epiphysis unites last (approximately 25 years) and anchors the upper-limit age estimate", "x": [["B) The lower end of the radius", "The lower end of the radius unites at about 18-19 years, well before the clavicle."], ["C) The iliac crest", "The iliac crest epiphysis unites around 16-17 years — an important juvenile-adult landmark but not the last."], ["D) The head of the humerus", "The head of the humerus unites at about 20 years, earlier than the medial clavicle."]]}, {"n": 58, "s": "A worker collapses minutes after exposure to a chemical with a bitter-almond odour and is brought to the emergency department with suspected cyanide poisoning. Which antidote acts by directly binding cyanide ions to form cyanocobalamin, which is then excreted in the urine?", "o": [["A", "Cyanocobalamin"], ["B", "Sodium thiosulfate"], ["C", "Sodium nitrite"], ["D", "Hydroxocobalamin"]], "c": ["D)", "Hydroxocobalamin"], "co": "Cyanide poisoning — antidote mechanism (hydroxocobalamin)", "ct": "Recall (antidote-action pairing)", "w": "Hydroxocobalamin (vitamin B12a) chelates cyanide directly to form harmless cyanocobalamin, which is renally excreted — a key mechanism question for cyanide antidotes.", "d": "Hydroxocobalamin binds cyanide as cyanocobalamin; cyanocobalamin is the product, not the antidote", "t": "Synonym Swap — hydroxocobalamin and cyanocobalamin are one-letter-apart names with opposite roles in this antidote", "f": "Hydroxocobalamin = antidote; cyanocobalamin = inert product of the binding reaction", "r": "Hydroxocobalamin binds cyanide to cyanocobalamin; thiosulfate converts cyanide to thiocyanate; nitrite induces methemoglobinemia", "x": [["A) Cyanocobalamin", "Cyanocobalamin (vitamin B12) is the harmless compound FORMED when hydroxocobalamin binds cyanide — it is the product, not the antidote."], ["B) Sodium thiosulfate", "Sodium thiosulfate acts as a sulfur donor converting cyanide to thiocyanate — it does not directly bind cyanide ions."], ["C) Sodium nitrite", "Sodium nitrite works by inducing methemoglobinemia, which then binds cyanide — a different mechanism from direct chelation."]]}, {"n": 59, "s": "A 45-year-old farmer was treated for acute organophosphate poisoning with atropine and pralidoxime and made a full recovery from the cholinergic crisis. Three weeks later he presents with progressive weakness of both feet, bilateral foot drop, and impaired vibration sense in the legs. What is the most likely diagnosis?", "o": [["A", "Organophosphate-induced delayed neuropathy (OPIDN)"], ["B", "Recurrence of intermediate syndrome"], ["C", "Guillain-Barre syndrome"], ["D", "Relapse of the acute cholinergic crisis"]], "c": ["A)", "Organophosphate-induced delayed neuropathy (OPIDN)"], "co": "Organophosphate poisoning — organophosphate-induced delayed neuropathy (OPIDN)", "ct": "Analysis/synthesis (temporal course + neurologic pattern)", "w": "OPIDN is a distal, motor-predominant axonopathy appearing 2-4 weeks after acute organophosphate exposure, presenting as foot drop and distal weakness; the time course separates it from intermediate syndrome (24-96 hours) and the acute crisis (immediate).", "d": "Distal symmetric weakness with foot drop WEEKS after acute OP poisoning = OPIDN; intermediate syndrome occurs at 24-96 hours", "t": "Clinical Mimic — a Guillain-Barre-like flaccid weakness that is actually the delayed neurotoxic sequel of organophosphate exposure", "f": "Weakness after OP poisoning: days = intermediate syndrome, weeks = delayed neuropathy", "r": "OPIDN = distal weakness/foot drop 2-4 weeks after OP exposure; intermediate syndrome = proximal/neck flexor weakness at 1-4 days", "x": [["B) Recurrence of intermediate syndrome", "Intermediate syndrome appears 1-4 days after exposure with neck-flexor and proximal weakness and respiratory failure — too early for a three-week presentation."], ["C) Guillain-Barre syndrome", "Guillain-Barre usually follows an infection, ascends symmetrically with areflexia, and is not a recognised sequel of organophosphate poisoning."], ["D) Relapse of the acute cholinergic crisis", "Relapse of cholinergic crisis would produce muscarinic and nicotinic signs (secretions, fasciculations), not isolated distal weakness with foot drop."]]}, {"n": 60, "s": "A body is recovered from the sea after several minutes of witnessed immersion. Bystanders pulled the victim out almost immediately, but resuscitation failed. Which biochemical pattern best matches saltwater (seawater) drowning?", "o": [["A", "Haemodilution with hyponatremia and hypervolemia"], ["B", "Haemoconcentration with hypernatremia and hypovolemia"], ["C", "Hyperkalemia from massive haemolysis"], ["D", "Left ventricular failure from acute volume overload"]], "c": ["B)", "Haemoconcentration with hypernatremia and hypovolemia"], "co": "Drowning — fresh vs salt water pathophysiology", "ct": "Analysis/synthesis (biochemical integration of drowning type)", "w": "Seawater is hypertonic, so aspirated saltwater draws fluid from the plasma into the alveoli, producing haemoconcentration, hypernatremia, and hypovolemia; freshwater drowning produces the mirror-image pattern of haemodilution, hyponatremia, and hyperkalemia from haemolysis.", "d": "Saltwater is hypertonic and draws plasma into the alveoli → haemoconcentration, hypernatremia, hypovolemia; freshwater is the mirror image", "t": "Opposite — the fresh and saltwater drowning patterns are mirror images, so the wrong option is usually the freshwater pattern", "f": "Saltwater = haemoconcentration and hypovolemia; freshwater = haemodilution, hyponatremia, hyperkalemia", "r": "Saltwater drowning → haemoconcentration, hypernatremia, hypovolemia; freshwater → haemodilution, hyponatremia, hyperkalemia", "x": [["A) Haemodilution with hyponatremia and hypervolemia", "Haemodilution, hyponatremia, and hypervolemia are the pattern of FRESHwater drowning, the mirror image of the saltwater picture."], ["C) Hyperkalemia from massive haemolysis", "Hyperkalemia from haemolysis occurs in freshwater drowning, where hypotonic water enters the blood and lyses red cells."], ["D) Left ventricular failure from acute volume overload", "Acute volume overload and left ventricular failure are features of freshwater drowning, not of the hypovolemic saltwater pattern."]]}, {"n": 61, "s": "A 3-year-old boy with pica is brought in with abdominal colic, irritability, and vomiting. He has microcytic anaemia with basophilic stippling on the blood film, and radiographs show dense metaphyseal bands at the wrists. He now develops altered consciousness and seizures. Which treatment is most appropriate?", "o": [["A", "Oral succimer (DMSA) alone"], ["B", "Parenteral dimercaprol (BAL) plus calcium disodium edetate"], ["C", "Deferoxamine infusion"], ["D", "Prussian blue"]], "c": ["B)", "Parenteral dimercaprol (BAL) plus calcium disodium edetate"], "co": "Lead poisoning — chelation in encephalopathy", "ct": "Analysis/synthesis (severity escalation of therapy)", "w": "Lead encephalopathy is a medical emergency requiring parenteral chelation with dimercaprol (BAL) combined with calcium disodium edetate; oral succimer alone is reserved for mild or asymptomatic lead poisoning.", "d": "Colic + basophilic stippling + metaphyseal bands + encephalopathy = severe lead poisoning → BAL + CaNa2EDTA", "t": "Treatment ladder — mild lead poisoning is managed with oral succimer, but encephalopathy mandates the parenteral BAL-EDTA combination", "f": "Basophilic stippling + lead lines + seizures = chelate aggressively with BAL + EDTA", "r": "Lead encephalopathy → dimercaprol (BAL) + CaNa2EDTA; mild/moderate lead → oral succimer (DMSA)", "x": [["A) Oral succimer (DMSA) alone", "Oral succimer is used for mild-to-moderate lead poisoning without encephalopathy — parenteral combination therapy is required once encephalopathy develops."], ["C) Deferoxamine infusion", "Deferoxamine treats iron overload, not lead poisoning."], ["D) Prussian blue", "Prussian blue is the treatment for thallium poisoning, not lead."]]}, {"n": 62, "s": "A family demands the exhumation of a buried body because they suspect poisoning. Under the applicable legal provisions, which authority can order the exhumation of a dead body?", "o": [["A", "The District Magistrate or a court"], ["B", "The Senior Superintendent of Police on his own authority"], ["C", "The treating hospital's medical board"], ["D", "A written request from the head of the family"]], "c": ["A)", "The District Magistrate or a court"], "co": "Exhumation — legal authority for the order", "ct": "Recall (legal provision governing exhumation)", "w": "Exhumation is a grave legal step that can only be ordered by the District Magistrate or a court; it is then conducted in the presence of the magistrate, police, and a medical officer, and the body is reinterred afterwards.", "d": "Exhumation requires an order from the District Magistrate or a court; police, hospital, and family requests alone are insufficient", "t": "Guideline Version — the operative legal provision vests the exhumation order with the magistrate/court, not the police, hospital, or family", "f": "Exhumation = magistrate/court order only; conducted with police + doctor present", "r": "Exhumation is ordered by the District Magistrate or a court and is conducted in the presence of a magistrate, police, and doctor", "x": [["B) The Senior Superintendent of Police on his own authority", "Police alone cannot authorise exhumation — a magistrate or court order is required by law."], ["C) The treating hospital's medical board", "A hospital medical board has no legal power to order the disinterment of a buried body."], ["D) A written request from the head of the family", "The wish of the family, however genuine, does not authorise exhumation; the magistrate or court must order it."]]}, {"n": 63, "s": "A body is brought to the mortuary about four hours after death. Rigor mortis is felt in the muscles of the eyelids, jaw, and neck but not yet in the lower limbs. According to Nysten's law, in which muscle group does rigor mortis first appear?", "o": [["A", "Eyelids and facial muscles"], ["B", "Muscles of the fingers"], ["C", "Muscles of the lower limbs"], ["D", "Muscles of the chest and abdomen"]], "c": ["A)", "Eyelids and facial muscles"], "co": "Postmortem changes — rigor mortis and Nysten's law", "ct": "Recall (order of appearance of rigor mortis)", "w": "Rigor mortis follows a craniocaudal progression (Nysten's law): it begins in the eyelids and facial muscles, then the jaw, neck, upper limbs, trunk, and finally the lower limbs, becoming fully established in about 6-12 hours.", "d": "Nysten's law: rigor appears first in the eyelids and face, then jaw, neck, upper limbs, and finally lower limbs", "t": "Nysten's law — the craniocaudal order of rigor, with the face first and the legs last", "f": "Rigor: face first, legs last; fully developed 6-12 hours, disappears 24-48 hours", "r": "Rigor mortis begins in the eyelids/face (Nysten's law) and spreads to the jaw, neck, upper and then lower limbs", "x": [["B) Muscles of the fingers", "The small muscles of the fingers stiffen later; the earliest rigor is in the eyelids and face."], ["C) Muscles of the lower limbs", "The lower limbs are the LAST group to develop rigor, not the first."], ["D) Muscles of the chest and abdomen", "Chest and abdominal muscles stiffen after the jaw and neck, in the craniocaudal sequence, so they cannot be first."]]}, {"n": 64, "s": "A man is found with a bruise on the left arm that is greenish-yellow at the periphery and fading. Based on the colour changes of a healing bruise, approximately how old is this bruise?", "o": [["A", "Less than 24 hours (bright red)"], ["B", "About 1-3 days (blue-black)"], ["C", "About 5-7 days (greenish-yellow)"], ["D", "More than 3 weeks (brown and fully faded)"]], "c": ["C)", "About 5-7 days (greenish-yellow)"], "co": "Mechanical injuries — ageing of bruises by colour", "ct": "Interpretation (colour chronology of a bruise)", "w": "A bruise passes through red (hours), blue-black (1-3 days), green (about 4-7 days), and yellow (7-14 days) as haemoglobin is broken down; a greenish-yellow bruise is therefore roughly one week old.", "d": "Greenish-yellow colour indicates a bruise about one week old as haemoglobin degrades through biliverdin to bilirubin", "t": "Colour-chronology mapping — the green-yellow transition marks the one-week milestone of bruise ageing", "f": "Red = hours, blue-black = days, green = week, yellow = 1-2 weeks", "r": "Bruise colour chronology: red -> blue-black (1-3 d) -> green (4-7 d) -> yellow (7-14 d)", "x": [["A) Less than 24 hours (bright red)", "A bright-red bruise indicates haemorrhage of only a few hours' duration, before colour change begins."], ["B) About 1-3 days (blue-black)", "A blue-black bruise corresponds to 1-3 days, when extravasated blood is still dark and deoxygenated."], ["D) More than 3 weeks (brown and fully faded)", "After about 2-3 weeks a bruise fades to brown and then disappears — a greenish-yellow bruise is much earlier in that timeline."]]}, {"n": 65, "s": "A body is found in an open field in summer, and forensic entomology is used to estimate the postmortem interval. The body is colonised by several arthropod species in waves. Which group is typically the FIRST to arrive and lay eggs on a fresh corpse?", "o": [["A", "Blowflies (Calliphoridae)"], ["B", "Dermestid beetles"], ["C", "Carrion beetles (Silphidae)"], ["D", "Ants and mites"]], "c": ["A)", "Blowflies (Calliphoridae)"], "co": "Forensic entomology — insect succession in postmortem interval estimation", "ct": "Recall/interpretation (insect-wave succession applied to PMI)", "w": "Blowflies (Calliphoridae) are the primary colonisers of a fresh corpse, often arriving within minutes to a few hours of death, and their developmental stages are the main tool for estimating the postmortem interval; beetles and mites appear in later waves of decomposition.", "d": "Blowflies detect and colonise a corpse within minutes to hours; beetles arrive in later decomposition stages", "t": "Organism homogeneity — all the options are arthropods that do colonise bodies, but only blowflies are the first wave", "f": "Blowflies first; beetles later; their succession dates the corpse", "r": "Blowflies (Calliphoridae) are the first colonisers; beetle and mite waves follow in later decomposition stages", "x": [["B) Dermestid beetles", "Dermestid beetles arrive in the dry/skeletal stages of decomposition, many weeks after death — they are late colonisers."], ["C) Carrion beetles (Silphidae)", "Carrion beetles appear after the blowfly maggot masses, feeding later in the decomposition sequence."], ["D) Ants and mites", "Ants and mites can be incidental or late arrivals and are not the primary first-wave colonisers used for PMI dating."]]}, {"n": 66, "s": "At autopsy of a man found dead at home after a domestic dispute, the only significant injury is a fracture of the greater cornu of the hyoid bone with perihyoid haemorrhage. There are no other neck injuries. Which conclusion is best supported by this finding?", "o": [["A", "Death was due to typical hanging"], ["B", "Death was due to judicial hanging"], ["C", "Death was due to smothering during an assault"], ["D", "Death was due to manual or ligature strangulation"]], "c": ["D)", "Death was due to manual or ligature strangulation"], "co": "Ligature and manual strangulation — hyoid bone fracture", "ct": "Interpretation (skeletal findings in asphyxial deaths)", "w": "The hyoid bone is the classic site of fracture in manual and ligature strangulation because pressure is applied low in the neck; surrounding haemorrhage proves the fracture was vital. In typical hanging the force is applied high above the thyroid cartilage and produces a high oblique ligature mark, with laryngeal or cervical spine injury rather than an isolated clean hyoid fracture.", "d": "An isolated hyoid fracture at the greater cornu with surrounding haemorrhage is the classic skeletal signature of manual or ligature strangulation", "t": "Pattern recognition — fracture signature: an isolated fractured hyoid with vital haemorrhage identifies strangulation, while the C2 'hangman's' fracture is the judicial-hanging red herring", "f": "Isolated hyoid fracture + perihyoid haemorrhage = strangulation; C2 fracture-dislocation = judicial hanging; high oblique mark = hanging", "r": "Hyoid fracture with perihyoid haemorrhage → manual or ligature strangulation; C2 'hangman's' fracture-dislocation → judicial hanging; typical hanging leaves a high oblique mark with laryngeal/C2 injury, not an isolated hyoid fracture", "x": [["A) Death was due to typical hanging", "Typical hanging applies force high in the neck (above the thyroid cartilage) and characteristically produces a high oblique mark; an isolated hyoid fracture is not its signature injury."], ["B) Death was due to judicial hanging", "Judicial hanging produces fracture-dislocation of the second cervical vertebra (the 'hangman's fracture') with cord injury — not an isolated hyoid fracture."], ["C) Death was due to smothering during an assault", "Smothering involves occlusion of the nose and mouth and leaves no neck injury at all, so a fractured hyoid with haemorrhage excludes it."]]}, {"n": 67, "s": "A 25-year-old woman ingests copper sulphate crystals in a suicide attempt and vomits blue-green material repeatedly. She is treated with gastric lavage after demulcents, dimercaprol, and supportive care for haemolysis and metabolic acidosis. Which of the following agents should NOT be added to her management?", "o": [["A", "Gastric lavage after milk or egg albumin"], ["B", "Dimercaprol (BAL)"], ["C", "Intravenous fluids and sodium bicarbonate for acidosis"], ["D", "Pralidoxime"]], "c": ["D)", "Pralidoxime"], "co": "Copper sulphate poisoning — management and antidote selection", "ct": "Interpretation (management completeness and exclusion)", "w": "Copper sulphate poisoning is managed with demulcents, gastric emptying, dimercaprol (BAL) chelation, and supportive care for haemolysis and acidosis; pralidoxime is an acetylcholinesterase reactivator for organophosphate poisoning and has no role here.", "d": "Blue-green vomiting after ingestion = copper sulphate; BAL and supportive care are correct, pralidoxime is an organophosphate antidote", "t": "What NOT to do — the antidote reflex borrowed from organophosphate poisoning is the trap", "f": "Blue-green vomitus = copper sulphate; treat with BAL + supportive care, never pralidoxime", "r": "Copper sulphate (blue-green vomit) → demulcents, BAL, supportive care; pralidoxime is not indicated", "x": [["A) Gastric lavage after milk or egg albumin", "Gastric lavage after demulcents such as milk or egg albumin is a correct part of copper sulphate management."], ["B) Dimercaprol (BAL)", "Dimercaprol (BAL) is the chelating agent used in copper sulphate poisoning and is correctly part of the regimen."], ["C) Intravenous fluids and sodium bicarbonate for acidosis", "Supportive care for haemolysis and metabolic acidosis, including fluids and bicarbonate, is a correct component of management."]]}, {"n": 68, "s": "A 60-year-old woman with 70% burns is conscious and coherent in the casualty ward. She says her son-in-law set her on fire and asks to give her statement before she dies. Who should ideally record her dying declaration?", "o": [["A", "A police constable from the local station"], ["B", "The nearest relative"], ["C", "The nurse on duty"], ["D", "An executive (first-class) magistrate"]], "c": ["D)", "An executive (first-class) magistrate"], "co": "Dying declaration — recording authority", "ct": "Analysis/synthesis (legal procedure in a dying victim)", "w": "A dying declaration should ideally be recorded by an executive (first-class) magistrate in the declarant's own words, with a fitness certificate; where no magistrate is available a doctor or police officer may record it, and it remains admissible — but the magistrate is the preferred recorder.", "d": "Dying declaration is recorded ideally by a magistrate; a doctor may record it if no magistrate is available, and it remains admissible", "t": "Recording authority — the magistrate is preferred, though a doctor's record in necessity is valid", "f": "Dying declaration = magistrate preferred; doctor valid in emergency; exact words + fitness certificate", "r": "Dying declaration recorded by a magistrate, or by a doctor/police officer in his absence, in the declarant's exact words", "x": [["A) A police constable from the local station", "A police constable is not the preferred recorder — the law designates a magistrate; police recording is a fallback only when no magistrate is available."], ["B) The nearest relative", "A relative has no legal role in recording a dying declaration; the statement must be recorded by an authorised official."], ["C) The nurse on duty", "The nurse is not an authorised recorder of dying declarations; the physician, not the nurse, acts as the fallback when a magistrate is unavailable."]]}, {"n": 69, "s": "A 40-year-old farmer is bitten on the ankle by a snake while harvesting. Two hours later there is only mild local swelling and mild pain at the bite site, but the 20-minute whole blood clotting test (20WBCT) shows blood that fails to clot. What is the most appropriate next step?", "o": [["A", "Excision of the bite wound under local anaesthesia"], ["B", "Tetanus toxoid and antibiotics alone, with daily wound review"], ["C", "Administer polyvalent antivenom without further delay"], ["D", "Observe in hospital without antivenom until local swelling becomes marked"]], "c": ["C)", "Administer polyvalent antivenom without further delay"], "co": "Snake bite — 20WBCT-guided antivenom decision", "ct": "Interpretation (bedside test → treatment trigger)", "w": "An incoagulable 20-minute whole blood clotting test is an indication of systemic (hemotoxic) envenomation and mandates antivenom even when local swelling is still mild — waiting for florid local signs delays life-saving therapy.", "d": "A non-clotting 20WBCT indicates systemic coagulopathy even with trivial local signs → antivenom now", "t": "Severity under-recognition — mild local swelling does not exclude severe systemic envenomation when the clotting test is abnormal", "f": "20WBCT non-clotting = give antivenom; local signs underestimate systemic toxicity", "r": "20WBCT >20 minutes (non-clotting) in a viper bite → polyvalent antivenom immediately", "x": [["A) Excision of the bite wound under local anaesthesia", "Wound excision has no role in snake bite management and may worsen tissue injury and infection risk."], ["B) Tetanus toxoid and antibiotics alone, with daily wound review", "Antibiotics and tetanus are adjuncts, not definitive therapy, once systemic coagulopathy has been demonstrated."], ["D) Observe in hospital without antivenom until local swelling becomes marked", "Observing without antivenom while the blood is incoagulable risks fatal bleeding — the abnormal clotting test is the trigger, not the degree of local swelling."]]}, {"n": 70, "s": "A 20-year-old woman is brought to the emergency department 90 minutes after an alleged sexual assault. She has multiple active bleeding lacerations, a pre-syncopal feeling, and a pulse of 120/min with blood pressure 85/55 mmHg. What is the most appropriate sequence of care?", "o": [["A", "Complete the full forensic examination first so evidence is not lost"], ["B", "Stabilise and treat the injuries first; carry out the medicolegal examination afterwards with consent"], ["C", "Send her to the police station for a statement before any examination"], ["D", "Perform the medicolegal examination and delay treatment until the investigating officer arrives"]], "c": ["B)", "Stabilise and treat the injuries first; carry out the medicolegal examination afterwards with consent"], "co": "Sexual offences — priority of medical care over forensic sampling", "ct": "Analysis/synthesis (priority sequencing in the examined victim)", "w": "In any medicolegal case the doctor's first duty is to the patient: life-threatening injuries are treated first, and the forensic examination is performed afterwards, with consent, once the patient is stable.", "d": "Haemodynamic instability + bleeding → resuscitation and injury care precede the forensic examination", "t": "Priority inversion — evidence collection must never delay resuscitation of the assault victim", "f": "Always: treat the patient first, then the evidence; document what was done and why", "r": "Resuscitation and injury treatment take precedence; forensic examination follows with consent in a stable patient", "x": [["A) Complete the full forensic examination first so evidence is not lost", "Delaying stabilisation to perform the forensic examination first can be fatal and is never correct."], ["C) Send her to the police station for a statement before any examination", "The patient needs medical care before any police statement; the doctor must not substitute the police for the clinical response."], ["D) Perform the medicolegal examination and delay treatment until the investigating officer arrives", "Delaying treatment until the investigating officer arrives subordinates medical care to the legal process — the wrong priority."]]}, {"n": 71, "s": "A man is struck on the head with a glass bottle during a brawl and collapses. At the emergency department he has a scalp wound with irregular, ragged, contused margins, strands of tissue bridging the gap, and bruising of the surrounding scalp. What is the nature of this wound?", "o": [["A", "An abrasion produced by friction against a rough surface"], ["B", "An incised wound produced by a sharp-edged weapon"], ["C", "A laceration produced by blunt force"], ["D", "A puncture wound produced by a pointed weapon"]], "c": ["C)", "A laceration produced by blunt force"], "co": "Mechanical injuries — laceration vs incised wound", "ct": "Interpretation (wound morphology → mechanism)", "w": "A laceration results from blunt force that crushes and splits the skin, so the margins are ragged and contused with strands of tissue bridging the defect, exactly as described. The glass bottle acted as the blunt vehicle; it did not convert the wound into an incised cut, which would have clean, sharp, non-contused edges with no bridging.", "d": "Ragged contused margins + tissue bridging at the wound = laceration from blunt force; the clean-edge/no-bridging pair is the incised signature and is absent here", "t": "Wound typing — bridging strands split a blunt laceration from an 'incised-looking' sharp cut", "f": "Ragged contused edges + tissue bridging = laceration (blunt); clean sharp edges + no bridging = incised (sharp)", "r": "Laceration = ragged contused margins with tissue bridging (blunt force); incised wound = clean sharp edges, gaping, no bridging (sharp weapon)", "x": [["A) An abrasion produced by friction against a rough surface", "An abrasion is a superficial scraping of the epidermis only, not a full-thickness irregular split with bruising of the surrounding scalp."], ["B) An incised wound produced by a sharp-edged weapon", "An incised wound has clean, sharp, non-contused edges without bridging; the ragged bruised margins here are the signature of a blunt-force laceration."], ["D) A puncture wound produced by a pointed weapon", "A puncture (stab) wound is deeper than it is wide and leaves a track, whereas this wound is a superficial gaping split with ragged margins."]]}, {"n": 72, "s": "A 2-year-old boy, previously well, develops 3 weeks of irritability, insomnia, profuse sweating, and photophobia. His hands and feet are red, swollen, and painful with peeling of the fingertips, and he is hypotonic. There is no fever. The family recently broke a mercury thermometer at home. What is the most likely diagnosis?", "o": [["A", "Acrodynia (chronic mercury poisoning)"], ["B", "Kawasaki disease"], ["C", "Erythema multiforme"], ["D", "Infantile eczema with secondary infection"]], "c": ["A)", "Acrodynia (chronic mercury poisoning)"], "co": "Mercury poisoning — acrodynia (pink disease)", "ct": "Interpretation (pediatric toxic syndrome recognition)", "w": "Acrodynia (pink disease) is chronic inorganic mercury poisoning in young children: irritability, photophobia, sweating, hypotonia, and red, painful, desquamating extremities; the absence of fever and the mercury exposure separate it from Kawasaki disease.", "d": "Red swollen peeling extremities + sweating + photophobia + NO fever + mercury exposure = acrodynia", "t": "Age-appropriate differential — in a toddler the Kawasaki look-alike is actually acrodynia from mercury", "f": "Feverless red desquamating hands/feet + sweating + photophobia = mercury, not Kawasaki", "r": "Acrodynia (pink disease) = chronic mercury in children; remove the source and chelate with succimer", "x": [["B) Kawasaki disease", "Kawasaki disease requires fever for at least 5 days plus conjunctivitis, rash, and cervical lymphadenopathy — no fever and the presence of sweating and photophobia point away from it."], ["C) Erythema multiforme", "Erythema multiforme presents with target lesions and mucosal involvement, not the sweating, photophobia, hypotonia, and peeling digits of acrodynia."], ["D) Infantile eczema with secondary infection", "Infantile eczema is pruritic and chronic but does not cause photophobia, sweating, hypotonia, or the redness and peeling confined to the extremities."]]}, {"n": 73, "s": "At autopsy on a body recovered from a house fire, extensive third-degree burns are present. Which single finding most reliably indicates that the burns were sustained BEFORE death (antemortem)?", "o": [["A", "Pugilistic attitude (fixed flexed posture) of the limbs"], ["B", "Splitting and cracking of the skin over the limbs"], ["C", "Heat stiffening of the muscles"], ["D", "Vesication containing fluid rich in leukocytes and fibrin, with a red congested line at the margins"]], "c": ["D)", "Vesication containing fluid rich in leukocytes and fibrin, with a red congested line at the margins"], "co": "Thermal injuries — antemortem vs postmortem burns", "ct": "Interpretation (vital reaction vs heat artifacts)", "w": "Antemortem burns show a vital reaction: blisters with protein-rich fluid containing leukocytes and fibrin and a congested red margin. Pugilistic attitude, skin splitting, and heat stiffening are heat effects that occur in both antemortem and postmortem burning.", "d": "Only a vital reaction (inflammatory exudate in blisters + marginal hyperemia) proves the burn was antemortem; posture, splitting, and stiffening occur in postmortem burning too", "t": "Vital-reaction recognition — dramatic heat artifacts mimic life but prove nothing about vitality", "f": "Vital reaction = antemortem; pugilistic attitude and skin splitting occur in dead bodies burned after death", "r": "Antemortem burn = vesication with inflammatory fluid and marginal congestion; heat artifacts alone do not prove vitality", "x": [["A) Pugilistic attitude (fixed flexed posture) of the limbs", "The pugilistic attitude results from heat coagulation of muscles and occurs whether the body was burned before or after death."], ["B) Splitting and cracking of the skin over the limbs", "Splitting of the skin from heat is a postmortem artifact of burning and carries no vital significance."], ["C) Heat stiffening of the muscles", "Heat stiffening of muscles is again a purely physical heat effect, identical in bodies burned after death."]]}, {"n": 74, "s": "A 55-year-old man is brought in unconscious after a road traffic accident with a ruptured spleen and intra-abdominal bleeding. Despite an urgent search his relatives cannot be traced, and surgery cannot wait. What is the correct medicolegal course of action?", "o": [["A", "Transfer the patient to another hospital that will accept him without consent"], ["B", "Delay surgery until written consent from a relative or guardian is obtained"], ["C", "Proceed with the life-saving surgery, documenting that consent was implied by emergency necessity"], ["D", "Obtain consent from any bystander who accompanied the patient"]], "c": ["C)", "Proceed with the life-saving surgery, documenting that consent was implied by emergency necessity"], "co": "Consent — the emergency (implied consent) doctrine", "ct": "Analysis/synthesis (legal principle applied to a life-threatening scenario)", "w": "In an emergency threatening life, consent is implied by necessity: the doctor may perform the intervention required to save life or prevent serious harm, documenting the situation and informing the administration afterwards.", "d": "Life-threatening emergency + no relative traceable → consent is implied by necessity; proceed and document", "t": "Overthinking — outpatient consent formalities do not apply when a patient's life is in immediate danger from a delay", "f": "Emergency + incapable patient + no relative = implied consent; document and inform", "r": "Life-saving emergency care proceeds without formal consent when the patient is incapable and no relative is available; document the basis", "x": [["A) Transfer the patient to another hospital that will accept him without consent", "Transferring a patient who cannot consent and who needs immediate surgery is unsafe and does not resolve the legal question."], ["B) Delay surgery until written consent from a relative or guardian is obtained", "Delaying surgery to hunt for relatives would endanger the patient's life — the emergency exception to consent applies."], ["D) Obtain consent from any bystander who accompanied the patient", "A bystander has no legal standing to give consent; consent here is implied by the clinical necessity itself."]]}, {"n": 75, "s": "At autopsy, a body shows intense cherry-red (pink) postmortem lividity in dependent areas and the stomach contents smell strongly of bitter almonds. Which poison is the most likely cause of death?", "o": [["A", "Carbon monoxide"], ["B", "Cyanide"], ["C", "Methanol"], ["D", "Strychnine"]], "c": ["B)", "Cyanide"], "co": "Cyanide poisoning — autopsy findings", "ct": "Interpretation (postmortem pattern recognition)", "w": "Bright cherry-red lividity and congestion with a bitter-almond odour from the stomach contents are the classic autopsy findings of cyanide poisoning; carbon monoxide also colours the lividity pink but does not produce the almond odour.", "d": "Cherry-red lividity alone is shared with CO poisoning; the bitter-almond gastric odour points to cyanide", "t": "Pattern recognition — two poisons share the cherry-red lividity; the gastric odour is the tie-breaker", "f": "Cherry-red lividity + bitter almonds = cyanide; cherry-red without the odour = carbon monoxide", "r": "Cyanide death = cherry-red lividity + bitter-almond odour + rapid course; confirm with toxicology", "x": [["A) Carbon monoxide", "Carbon monoxide also produces cherry-red lividity and pink tissues, but there is no bitter-almond odour of the gastric contents."], ["C) Methanol", "Methanol produces cyanosed or congested organs with putamen necrosis and ocular findings — not cherry-red lividity or an almond odour."], ["D) Strychnine", "Strychnine causes convulsive death with intense rigor and asphyxial changes — not cherry-red lividity or an almond smell."]]}, {"n": 76, "s": "A 40-year-old woman presents with chronic diarrhoea, hyperpigmentation of the skin with raindrop depigmentation, peripheral neuropathy, and white transverse bands across all fingernails (Mees lines). She has been taking an unregulated herbal tonic for months. Which chelating agent is the most appropriate treatment?", "o": [["A", "Calcium disodium edetate (CaNa2EDTA)"], ["B", "Dimercaprol (BAL)"], ["C", "D-penicillamine"], ["D", "Deferoxamine"]], "c": ["B)", "Dimercaprol (BAL)"], "co": "Arsenic poisoning — clinical picture and chelation", "ct": "Interpretation (chronic intoxication pattern → antidote)", "w": "Mees lines, raindrop (rain-drop) pigmentation, peripheral neuropathy and chronic diarrhoea are classic chronic arsenic poisoning; dimercaprol (BAL) is the conventional chelating agent for arsenic intoxication.", "d": "Mees lines + raindrop pigmentation + neuropathy + herbal tonic = chronic arsenic poisoning → dimercaprol", "t": "Treatment misdirection — penicillamine is the Wilson disease reflex, not the arsenic chelator", "f": "Mees lines + raindrop pigmentation = arsenic; chelate with BAL/DMSA", "r": "Arsenic (Mees lines, pigmentation, garlic odour) → chelation with dimercaprol (BAL)", "x": [["A) Calcium disodium edetate (CaNa2EDTA)", "Calcium disodium edetate is the lead chelator (with dimercaprol in encephalopathy) and is not the agent of choice for arsenic."], ["C) D-penicillamine", "D-penicillamine is the treatment for Wilson disease (copper overload) and has no role as first-line therapy for arsenic poisoning."], ["D) Deferoxamine", "Deferoxamine is the iron-chelating agent used in acute iron overload — it does not chelate arsenic."]]}, {"n": 77, "s": "A 48-year-old man undergoes an elective cholecystectomy under general anaesthesia and dies on the operating table despite rapid resuscitation. The family had signed a detailed surgical consent form. According to current medicolegal practice, how should this death be handled?", "o": [["A", "The signed consent form absolves the team of any medicolegal reporting obligation"], ["B", "It is a natural death and needs no reporting to the authorities"], ["C", "It is a medicolegal case and should be reported; autopsy proceeds on the order of the magistrate"], ["D", "It becomes reportable only if the family lodges a formal complaint"]], "c": ["C)", "It is a medicolegal case and should be reported; autopsy proceeds on the order of the magistrate"], "co": "Medico-legal cases — perioperative (anaesthetic) death", "ct": "Analysis/synthesis (applying the MLC definition to a clinical event)", "w": "Death under anaesthesia is a sudden and unexpected death in which medical negligence is suspected until proved otherwise; it is a medicolegal case that must be reported, and autopsy is performed on the magistrate's order — a signed consent form does not change this.", "d": "Death during anaesthesia/surgery = sudden, unexpected death suspecting negligence → medicolegal case irrespective of signed consent", "t": "Iatrogenic trap — the very treatment setting makes the death reportable; consent for surgery is not consent to waive medicolegal scrutiny", "f": "Death on the table = MLC; report and await magistrate's order; consent forms change nothing", "r": "Perioperative death = medicolegal case; report to police, autopsy on magistrate's order", "x": [["A) The signed consent form absolves the team of any medicolegal reporting obligation", "Informed consent for surgery addresses the procedure itself, not the medicolegal reporting of an unexpected perioperative death."], ["B) It is a natural death and needs no reporting to the authorities", "A death during anaesthesia is sudden, unexpected, and raises the possibility of negligence — it is not a natural-death certificate scenario."], ["D) It becomes reportable only if the family lodges a formal complaint", "The medicolegal obligation exists independent of any complaint by the family; reporting is not conditional on an accusation."]]}, {"n": 78, "s": "A 22-year-old woman is examined 5 hours after an alleged rape. She is haemodynamically stable and consents to the examination. Which investigation most reliably corroborates recent sexual intercourse at this time point?", "o": [["A", "Serum beta-hCG level"], ["B", "High vaginal swab for bacterial culture"], ["C", "Urine toxicology screen"], ["D", "Microscopic examination of a vaginal swab for motile spermatozoa"]], "c": ["D)", "Microscopic examination of a vaginal swab for motile spermatozoa"], "co": "Sexual offences — corroborative evidence of recent intercourse", "ct": "Analysis/synthesis (choosing the discriminating forensic test)", "w": "Demonstration of motile spermatozoa on a wet-mount (saline) preparation of a vaginal swab is the classic immediate corroboration of recent intercourse; beta-hCG, culture, and toxicology address pregnancy, infection, and drugs respectively, not the act itself.", "d": "Within hours of intercourse, motile spermatozoa can be seen on wet-mount microscopy; the other tests answer different questions", "t": "Investigation hierarchy — the simplest bedside microscopy is the discriminating test here, not serum or culture-based panels", "f": "Motile spermatozoa = recent intercourse; immobilised spermatozoa = older exposure; absence does not exclude assault", "r": "Vaginal wet-mount microscopy for motile spermatozoa is the immediate corroborative test for recent intercourse", "x": [["A) Serum beta-hCG level", "Serum beta-hCG detects pregnancy and is irrelevant to confirming intercourse that occurred only hours ago."], ["B) High vaginal swab for bacterial culture", "Vaginal culture identifies infection, not the occurrence of recent intercourse."], ["C) Urine toxicology screen", "Urine toxicology screening is for drugs or poisons and has no role in corroborating recent intercourse."]]}, {"n": 79, "s": "A 40-year-old man known to use opium is found drowsy at home. In the emergency department he is comatose with a respiratory rate of 7/min and shallow breathing. Which single finding on examination would most strongly argue AGAINST the opium toxidrome as the explanation for his coma?", "o": [["A", "Pinpoint (miotic) pupils"], ["B", "Marked bradycardia"], ["C", "Bilaterally dilated pupils"], ["D", "Hypothermia"]], "c": ["C)", "Bilaterally dilated pupils"], "co": "Opium (opioid) poisoning — the classic toxidrome and its contradictions", "ct": "Recall/interpretation (toxidrome pattern matching)", "w": "Coma with respiratory depression and miosis is the classic opioid toxidrome; bilaterally dilated pupils are the opposite and should redirect the diagnosis toward atropinic, sympathomimetic, or other agents.", "d": "Opioid toxidrome = coma + respiratory depression + pinpoint pupils; mydriasis contradicts the diagnosis", "t": "Negative discrimination — the 'one finding that does not fit' question: mydriasis excludes the textbook opioid picture", "f": "Coma + bradypnoea + pinpoint pupils = opioid until proven otherwise; dilated pupils = think again", "r": "Opioid toxidrome = miosis + respiratory depression + coma; mydriasis is against it", "x": [["A) Pinpoint (miotic) pupils", "Pinpoint pupils are a hallmark of opioid poisoning — this supports rather than contradicts the toxidrome."], ["B) Marked bradycardia", "Bradycardia, like hypothermia, is common in opioid poisoning and would be consistent with the diagnosis."], ["D) Hypothermia", "Hypothermia is a recognised accompaniment of opioid overdose, so it does not argue against the toxidrome."]]}, {"n": 80, "s": "During the dental examination of a child for medicolegal age estimation, the first permanent molar (the 'six-year molar') has recently erupted while the deciduous incisors are still being shed. Approximately what is the child's age?", "o": [["A", "About 12 years"], ["B", "About 15 years"], ["C", "About 6 years"], ["D", "About 9 years"]], "c": ["C)", "About 6 years"], "co": "Age estimation — dental eruption chronology", "ct": "Interpretation (dentition milestone → age)", "w": "The first permanent molar erupts at approximately 6 years of age, coinciding with shedding of the deciduous incisors; it is the first permanent tooth and a reliable dental age landmark.", "d": "First permanent molar erupts at about 6 years; the second permanent molar ('twelve-year molar') at 12", "t": "Unit/Number — the 6 and 12 year molars are the two classic numbers; mixing them up is the trap", "f": "First molar = 6 years; second molar = 12 years; third molar = 17-25 years", "r": "First permanent molar ('six-year molar') = about 6 years; second molar = 12 years", "x": [["A) About 12 years", "About 12 years corresponds to eruption of the second permanent molar, the 'twelve-year molar', not the first."], ["B) About 15 years", "By about 15 years the second molars are erupted and the canines and premolars are complete — far beyond the first-molar stage."], ["D) About 9 years", "At about 9 years the first permanent molar has long been erupted and the permanent incisors and first premolars are appearing."]]}], "c": 80}}

Test Series 2026